{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:04:10Z","timestamp":1794693850618,"version":"4.9.1"},"reference-count":380,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institutes of Health, United States","award":["U01 AG072177"],"award-info":[{"award-number":["U01 AG072177"]}]},{"name":"National Institutes of Health, United States","award":["U19 AG074879"],"award-info":[{"award-number":["U19 AG074879"]}]},{"name":"Alzheimer\u2019s Association Zenith Fellows Award"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG010133"],"award-info":[{"award-number":["P30 AG010133"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Avid Radiopharmaceuticals, a subsidiary of Eli Lilly"},{"DOI":"10.13039\/100021066","name":"Gates Ventures, LLC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100021066","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sanofi"},{"name":"Gift funds (GV) supporting technical contributions to the GRIP platform"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"DOI":"10.1186\/s13024-026-00934-4","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:17:43Z","timestamp":1771867063000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Systems biology of Alzheimer\u2019s Disease: a scoping review of key pathways and mechanisms"],"prefix":"10.1186","volume":"21","author":[{"given":"Paula J.","family":"Bice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsik","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil\u00fcfer","family":"Ertekin-Taner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"934_CR1","unstructured":"Association As. Alzheimer\u2019s Disease facts and Figs. 2025 Available from: https:\/\/www.alz.org\/Alzheimers-dementia\/facts-figures."},{"key":"934_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.conb.2020.02.003","volume":"61","author":"DM Walsh","year":"2020","unstructured":"Walsh DM, Selkoe DJ. Amyloid beta-protein and beyond: the path forward in Alzheimer\u2019s Disease. Curr Opin Neurobiol. 2020;61:116\u201324.","journal-title":"Curr Opin Neurobiol"},{"issue":"5","key":"934_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack Jr","year":"2016","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A\/T\/N: an unbiased descriptive classification scheme for Alzheimer Disease biomarkers. Neurology. 2016;87(5):539\u201347.","journal-title":"Neurology"},{"issue":"8","key":"934_CR4","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr., Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s Disease: Alzheimer\u2019s association workgroup. Alzheimers Dement. 2024;20(8):5143\u201369.","journal-title":"Alzheimers Dement"},{"issue":"5054","key":"934_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s Disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"issue":"9","key":"934_CR6","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38(9):1205\u201335.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"934_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1586\/14737159.2015.1002469","volume":"15","author":"C Reitz","year":"2015","unstructured":"Reitz C. Genetic diagnosis and prognosis of Alzheimer\u2019s Disease: challenges and opportunities. Expert Rev Mol Diagn. 2015;15(3):339\u201348.","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"934_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Chetelat G, Holtzman DM, Hyman BT, et al. Alzheimer Disease. Nat Rev Dis Primers. 2021;7(1):33.","journal-title":"Nat Rev Dis Primers"},{"issue":"7715","key":"934_CR9","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/d41586-018-05719-4","volume":"559","author":"S Makin","year":"2018","unstructured":"Makin S. The amyloid hypothesis on trial. Nature. 2018;559(7715):S4\u20137.","journal-title":"Nature"},{"issue":"1","key":"934_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1073\/pnas.94.1.298","volume":"94","author":"AD Alonso","year":"1997","unstructured":"Alonso AD, Grundke-Iqbal I, Barra HS, Iqbal K. Abnormal phosphorylation of Tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal Tau. Proc Natl Acad Sci U S A. 1997;94(1):298\u2013303.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"934_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4161\/pri.1.1.4055","volume":"1","author":"G Lippens","year":"2007","unstructured":"Lippens G, Sillen A, Landrieu I, Amniai L, Sibille N, Barbier P, et al. Tau aggregation in Alzheimer\u2019s Disease: what role for phosphorylation? Prion. 2007;1(1):21\u20135.","journal-title":"Prion"},{"issue":"8","key":"934_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/156720510793611592","volume":"7","author":"K Iqbal","year":"2010","unstructured":"Iqbal K, Liu F, Gong CX, Grundke-Iqbal I. Tau in Alzheimer Disease and related tauopathies. Curr Alzheimer Res. 2010;7(8):656\u201364.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"934_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/biom6010006","volume":"6","author":"G \u0160imi\u0107","year":"2016","unstructured":"\u0160imi\u0107 G, Babi\u0107 Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milo\u0161evi\u0107 N, et al. Tau protein hyperphosphorylation and aggregation in Alzheimer\u2019s Disease and other Tauopathies, and possible neuroprotective strategies. Biomolecules. 2016;6(1):6.","journal-title":"Biomolecules"},{"issue":"5","key":"934_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2174\/1570159X15666170720095240","volume":"16","author":"M Fakhoury","year":"2018","unstructured":"Fakhoury M. Microglia and astrocytes in Alzheimer\u2019s Disease: implications for therapy. Curr Neuropharmacol. 2018;16(5):508\u201318.","journal-title":"Curr Neuropharmacol"},{"key":"934_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer\u2019s Disease. Alzheimers Dement (N Y). 2018;4:575\u201390.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"934_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM. Alzheimer\u2019s Disease risk genes and mechanisms of Disease pathogenesis. Biol Psychiatry. 2015;77(1):43\u201351.","journal-title":"Biol Psychiatry"},{"issue":"s1","key":"934_CR17","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.3233\/JAD-179932","volume":"64","author":"H Hampel","year":"2018","unstructured":"Hampel H, Toschi N, Babiloni C, Baldacci F, Black KL, Bokde ALW, et al. Revolution of Alzheimer precision Neurology. Passageway of systems biology and neurophysiology. J Alzheimers Dis. 2018;64(s1):S47\u2013105.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"934_CR18","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/alz.12480","volume":"18","author":"D Tosun","year":"2022","unstructured":"Tosun D, Demir Z, Veitch DP, Weintraub D, Aisen P, Jack CR Jr., et al. Contribution of Alzheimer\u2019s biomarkers and risk factors to cognitive impairment and decline across the Alzheimer\u2019s Disease continuum. Alzheimers Dement. 2022;18(7):1370\u201382.","journal-title":"Alzheimers Dement"},{"key":"934_CR19","unstructured":"Rauf D. New approaches to Alzheimer\u2019s treatments: beyond amyloid plaques, Tau 2019 Available from:. https:\/\/www.everydayhealth.com\/Alzheimers-Disease\/new-approaches-Alzheimers-treatments-beyond-amyloid-plaques-tau\/."},{"key":"934_CR20","doi-asserted-by":"crossref","unstructured":"Lloret A, Esteve D, Lloret MA, Cervera-Ferri A, Lopez B, Nepomuceno M, et al. When does Alzheimer\u2019s Disease really start? The role of biomarkers. Int J Mol Sci. 2019;20(22).","DOI":"10.3390\/ijms20225536"},{"issue":"6","key":"934_CR21","first-page":"1370","volume":"19","author":"J Yan","year":"2018","unstructured":"Yan J, Risacher SL, Shen L, Saykin AJ. Network approaches to systems biology analysis of complex Disease: integrative methods for multi-omics data. Brief Bioinform. 2018;19(6):1370\u201381.","journal-title":"Brief Bioinform"},{"key":"934_CR22","doi-asserted-by":"publisher","first-page":"105558","DOI":"10.1016\/j.nbd.2021.105558","volume":"161","author":"B Gurdon","year":"2021","unstructured":"Gurdon B, Kaczorowski C. Pursuit of precision medicine: systems biology approaches in Alzheimer\u2019s Disease mouse models. Neurobiol Dis. 2021;161:105558.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"934_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-022-00517-z","volume":"17","author":"M Wang","year":"2022","unstructured":"Wang M, Song WM, Ming C, Wang Q, Zhou X, Xu P, et al. Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer\u2019s Disease: review, recommendation, implementation and application. Mol Neurodegener. 2022;17(1):17.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"934_CR24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jalz.2012.05.2115","volume":"8","author":"LM Refolo","year":"2012","unstructured":"Refolo LM, Snyder H, Liggins C, Ryan L, Silverberg N, Petanceska S, et al. Common Alzheimer\u2019s Disease research ontology: National Institute on aging and Alzheimer\u2019s association collaborative project. Alzheimers Dement. 2012;8(4):372\u20135.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"934_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12874-018-0611-x","volume":"18","author":"Z Munn","year":"2018","unstructured":"Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143.","journal-title":"BMC Med Res Methodol"},{"key":"934_CR26","unstructured":"PRISMA, PRISMA-scoping reviews. 2020 Available from: https:\/\/www.prisma-statement.org\/scoping."},{"issue":"2","key":"934_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s42256-020-00287-7","volume":"3","author":"R an de Schoot","year":"2021","unstructured":"an de Schoot R, de Bruin J, Schram R, Zahedi P, de Boer J, Weijdema F, et al. An open source machine learning framework for efficient and transparent systematic reviews. Nat Mach Intell. 2021;3(2):125\u201333.","journal-title":"Nat Mach Intell"},{"key":"934_CR28","doi-asserted-by":"crossref","unstructured":"Hu C, Yang J, Qi Z, Wu H, Wang B, Zou F, et al. Heat shock proteins: biological functions, pathological roles, and therapeutic opportunities. Med Commun (2020). 2022;3(3):e161.","DOI":"10.1002\/mco2.161"},{"key":"934_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-3-319-57379-3_20","volume":"987","author":"C Bobori","year":"2017","unstructured":"Bobori C, Theocharopoulou G, Vlamos P. Molecular chaperones in neurodegenerative Diseases: A short review. Adv Exp Med Biol. 2017;987:219\u201331.","journal-title":"Adv Exp Med Biol"},{"key":"934_CR30","doi-asserted-by":"crossref","unstructured":"Campanella C, Pace A, Caruso Bavisotto C, Marzullo P, Marino Gammazza A, Buscemi S, et al. Heat shock proteins in Alzheimer\u2019s Disease: role and targeting. Int J Mol Sci. 2018;19(9).","DOI":"10.3390\/ijms19092603"},{"key":"934_CR31","doi-asserted-by":"publisher","first-page":"435203","DOI":"10.1155\/2014\/435203","volume":"2014","author":"RC Lu","year":"2014","unstructured":"Lu RC, Tan MS, Wang H, Xie AM, Yu JT, Tan L. Heat shock protein 70 in Alzheimer\u2019s Disease. Biomed Res Int. 2014;2014:435203.","journal-title":"Biomed Res Int"},{"key":"934_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fnins.2017.00254","volume":"11","author":"RE Lackie","year":"2017","unstructured":"Lackie RE, Maciejewski A, Ostapchenko VG, Marques-Lopes J, Choy WY, Duennwald ML, et al. The Hsp70\/Hsp90 chaperone machinery in neurodegenerative Diseases. Front Neurosci. 2017;11:254.","journal-title":"Front Neurosci"},{"key":"934_CR33","doi-asserted-by":"crossref","unstructured":"Bohush A, Bieganowski P, Filipek A. Hsp90 and its co-chaperones in neurodegenerative Diseases. Int J Mol Sci. 2019;20(20).","DOI":"10.3390\/ijms20204976"},{"key":"934_CR34","doi-asserted-by":"publisher","first-page":"115859","DOI":"10.1016\/j.ejmech.2023.115859","volume":"261","author":"C He","year":"2023","unstructured":"He C, Gu J, Wang D, Wang K, Wang Y, You Q, et al. Small molecules targeting molecular chaperones for Tau regulation: achievements and challenges. Eur J Med Chem. 2023;261:115859.","journal-title":"Eur J Med Chem"},{"key":"934_CR35","doi-asserted-by":"publisher","first-page":"1281338","DOI":"10.3389\/fnagi.2023.1281338","volume":"15","author":"H Barmaki","year":"2023","unstructured":"Barmaki H, Nourazarian A, Khaki-Khatibi F. Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer\u2019s Disease. Front Aging Neurosci. 2023;15:1281338.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"934_CR36","doi-asserted-by":"publisher","first-page":"101905","DOI":"10.1016\/j.jbc.2022.101905","volume":"298","author":"BS Rutledge","year":"2022","unstructured":"Rutledge BS, Choy WY, Duennwald ML. Folding or holding?-Hsp70 and Hsp90 chaperoning of misfolded proteins in neurodegenerative Disease. J Biol Chem. 2022;298(5):101905.","journal-title":"J Biol Chem"},{"key":"934_CR37","doi-asserted-by":"publisher","first-page":"112915","DOI":"10.1016\/j.ejmech.2020.112915","volume":"209","author":"L Wang","year":"2021","unstructured":"Wang L, Bharti, Kumar R, Pavlov PF, Winblad B. Small molecule therapeutics for tauopathy in Alzheimer\u2019s Disease: walking on the path of most resistance. Eur J Med Chem. 2021;209:112915.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"934_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/09727531211070528","volume":"29","author":"G Beretta","year":"2022","unstructured":"Beretta G, Shala AL. Impact of heat shock proteins in neurodegeneration: possible therapeutical targets. Ann Neurosci. 2022;29(1):71\u201382.","journal-title":"Ann Neurosci"},{"issue":"6","key":"934_CR39","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1080\/15548627.2022.2160564","volume":"19","author":"B Tedesco","year":"2023","unstructured":"Tedesco B, Vendredy L, Timmerman V, Poletti A. The chaperone-assisted selective autophagy complex dynamics and dysfunctions. Autophagy. 2023;19(6):1619\u201341.","journal-title":"Autophagy"},{"issue":"10","key":"934_CR40","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1517\/14728222.2014.943185","volume":"18","author":"LJ Blair","year":"2014","unstructured":"Blair LJ, Sabbagh JJ, Dickey CA. Targeting Hsp90 and its co-chaperones to treat Alzheimer\u2019s Disease. Expert Opin Ther Targets. 2014;18(10):1219\u201332.","journal-title":"Expert Opin Ther Targets"},{"issue":"36","key":"934_CR41","doi-asserted-by":"publisher","first-page":"9707","DOI":"10.1073\/pnas.1707039114","volume":"114","author":"LB Shelton","year":"2017","unstructured":"Shelton LB, Baker JD, Zheng D, Sullivan LE, Solanki PK, Webster JM, et al. Hsp90 activator Aha1 drives production of pathological Tau aggregates. Proc Natl Acad Sci U S A. 2017;114(36):9707\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"934_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.mcn.2017.11.013","volume":"86","author":"WW Yu","year":"2018","unstructured":"Yu WW, Cao SN, Zang CX, Wang L, Yang HY, Bao XQ, et al. Heat shock protein 70 suppresses neuroinflammation induced by \u03b1-synuclein in astrocytes. Mol Cell Neurosci. 2018;86:58\u201364.","journal-title":"Mol Cell Neurosci"},{"key":"934_CR43","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3389\/fphar.2019.00920","volume":"10","author":"B Dukay","year":"2019","unstructured":"Dukay B, Csoboz B, T\u00f3th ME. Heat-Shock proteins in neuroinflammation. Front Pharmacol. 2019;10:920.","journal-title":"Front Pharmacol"},{"key":"934_CR44","first-page":"89","volume-title":"Heat shock proteins in inflammatory Diseases","author":"K Panchal","year":"2021","unstructured":"Panchal K, Bhatt V, Raval M, Tiwari AK. Heat shock Proteins, a key modulator of neuroinflammation in Alzheimer\u2019s Disease. In: Asea AAA, Kaur P, editors. Heat shock proteins in inflammatory Diseases. Cham: Springer International Publishing; 2021. pp. 89\u2013145."},{"key":"934_CR45","doi-asserted-by":"crossref","unstructured":"Wei H, Zhang Y, Jia Y, Chen X, Niu T, Chatterjee A, et al. Heat shock protein 90: biological functions, Diseases, and therapeutic targets. Med Commun (2020). 2024;5(2):e470.","DOI":"10.1002\/mco2.470"},{"issue":"11","key":"934_CR46","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","volume":"1843","author":"MD Turner","year":"2014","unstructured":"Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory Disease. Biochim Biophys Acta. 2014;1843(11):2563\u201382.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"934_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5483\/BMBRep.2020.53.1.309","volume":"53","author":"JC Park","year":"2020","unstructured":"Park JC, Han SH, Mook-Jung I. Peripheral inflammatory biomarkers in Alzheimer\u2019s Disease: a brief review. BMB Rep. 2020;53(1):10\u20139.","journal-title":"BMB Rep"},{"issue":"8","key":"934_CR48","doi-asserted-by":"publisher","first-page":"870","DOI":"10.2174\/1567205014666170317113606","volume":"14","author":"C Domingues","year":"2017","unstructured":"Domingues C, da Cruz ESOAB, Henriques AG. Impact of cytokines and chemokines on Alzheimer\u2019s Disease neuropathological hallmarks. Curr Alzheimer Res. 2017;14(8):870\u201382.","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"934_CR49","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","volume":"90","author":"XN Shen","year":"2019","unstructured":"Shen XN, Niu LD, Wang YJ, Cao XP, Liu Q, Tan L, et al. Inflammatory markers in Alzheimer\u2019s Disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies. J Neurol Neurosurg Psychiatry. 2019;90(5):590\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"934_CR50","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy ER, Wang B, Wan YW, Chiu G, Cole A, Yin Z, et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer Disease. J Clin Invest. 2020;130(4):1912\u201330.","journal-title":"J Clin Invest"},{"key":"934_CR51","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368.","journal-title":"Annu Rev Immunol"},{"key":"934_CR52","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","volume":"79","author":"SA Wolf","year":"2017","unstructured":"Wolf SA, Boddeke HW, Kettenmann H. Microglia in physiology and Disease. Annu Rev Physiol. 2017;79:619\u201343.","journal-title":"Annu Rev Physiol"},{"key":"934_CR53","doi-asserted-by":"publisher","first-page":"620581","DOI":"10.1155\/2015\/620581","volume":"2015","author":"M Brkic","year":"2015","unstructured":"Brkic M, Balusu S, Libert C, Vandenbroucke RE. Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative Diseases. Mediators Inflamm. 2015;2015:620581.","journal-title":"Mediators Inflamm"},{"key":"934_CR54","doi-asserted-by":"publisher","first-page":"3087475","DOI":"10.1155\/2018\/3087475","volume":"2018","author":"F Alasmari","year":"2018","unstructured":"Alasmari F, Alshammari MA, Alasmari AF, Alanazi WA, Alhazzani K. Neuroinflammatory cytokines induce amyloid beta neurotoxicity through modulating amyloid precursor protein Levels\/Metabolism. Biomed Res Int. 2018;2018:3087475.","journal-title":"Biomed Res Int"},{"issue":"1","key":"934_CR55","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12974-018-1313-3","volume":"15","author":"EA Newcombe","year":"2018","unstructured":"Newcombe EA, Camats-Perna J, Silva ML, Valmas N, Huat TJ, Medeiros R. Inflammation: the link between comorbidities, genetics, and Alzheimer\u2019s Disease. J Neuroinflammation. 2018;15(1):276.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"934_CR56","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R van der Sims","year":"2017","unstructured":"van der Sims R, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s Disease. Nat Genet. 2017;49(9):1373\u201384.","journal-title":"Nat Genet"},{"key":"934_CR57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-015-0016-9","volume":"10","author":"SC Jin","year":"2015","unstructured":"Jin SC, Carrasquillo MM, Benitez BA, Skorupa T, Carrell D, Patel D, et al. TREM2 is associated with increased risk for Alzheimer\u2019s Disease in African Americans. Mol Neurodegener. 2015;10:19.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"934_CR58","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jalz.2016.10.005","volume":"13","author":"MM Carrasquillo","year":"2017","unstructured":"Carrasquillo MM, Allen M, Burgess JD, Wang X, Strickland SL, Aryal S, et al. A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer\u2019s Disease risk and increased TREML1 and TREM2 brain gene expression. Alzheimers Dement. 2017;13(6):663\u201373.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"934_CR59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-018-0289-x","volume":"13","author":"OJ Conway","year":"2018","unstructured":"Conway OJ, Carrasquillo MM, Wang X, Bredenberg JM, Reddy JS, Strickland SL, et al. ABI3 and PLCG2 missense variants as risk factors for neurodegenerative Diseases in Caucasians and African Americans. Mol Neurodegener. 2018;13(1):53.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"934_CR60","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00401-019-02026-8","volume":"138","author":"SJ n der Lee","year":"2019","unstructured":"n der Lee SJ, Conway OJ, Jansen I, Carrasquillo MM, van den Kleineidam L, et al. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer\u2019s Disease, dementia with lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathol. 2019;138(2):237\u201350.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"934_CR61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13195-019-0469-0","volume":"11","author":"L Magno","year":"2019","unstructured":"Magno L, Lessard CB, Martins M, Lang V, Cruz P, Asi Y, et al. Alzheimer\u2019s Disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. Alzheimers Res Ther. 2019;11(1):16.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"934_CR62","first-page":"416","volume":"26","author":"B van Lengerich","year":"2023","unstructured":"van Lengerich B, Zhan L, Xia D, Chan D, Joy D, Park JI, et al. A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s Disease models. Nat Neurosci. 2023;26(3):416\u201329.","journal-title":"Nat Neurosci"},{"issue":"8","key":"934_CR63","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.stem.2023.07.006","volume":"30","author":"Y Yoo","year":"2023","unstructured":"Yoo Y, Neumayer G, Shibuya Y, Mader MM, Wernig M. A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer\u2019s Disease. Cell Stem Cell. 2023;30(8):1043\u2013e536.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"934_CR64","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, et al. TREM2 is a receptor for \u03b2-Amyloid that mediates microglial function. Neuron. 2018;97(5):1023\u2013e317.","journal-title":"Neuron"},{"issue":"1","key":"934_CR65","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/s41467-019-09118-9","volume":"10","author":"L Zhong","year":"2019","unstructured":"Zhong L, Xu Y, Zhuo R, Wang T, Wang K, Huang R, et al. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s Disease model. Nat Commun. 2019;10(1):1365.","journal-title":"Nat Commun"},{"issue":"2","key":"934_CR66","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/10738584241254118","volume":"31","author":"Q Shi","year":"2025","unstructured":"Shi Q, Gutierrez RA, Bhat MA, Microglia. Trem2, and neurodegeneration. Neuroscientist. 2025;31(2):159\u201376.","journal-title":"Neuroscientist"},{"issue":"1","key":"934_CR67","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3233\/JAD-160663","volume":"55","author":"AA Raha","year":"2017","unstructured":"Raha AA, Henderson JW, Stott SR, Vuono R, Foscarin S, Friedland RP, et al. Neuroprotective effect of TREM-2 in aging and Alzheimer\u2019s Disease model. J Alzheimers Dis. 2017;55(1):199\u2013217.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"934_CR68","doi-asserted-by":"publisher","first-page":"54","DOI":"10.14283\/jfa.2018.43","volume":"8","author":"C Gussago","year":"2019","unstructured":"Gussago C, Casati M, Ferri E, Arosio B. The triggering receptor expressed on myeloid Cells-2 (TREM-2) as expression of the relationship between microglia and Alzheimer\u2019s Disease: A novel marker for a promising pathway to explore. J Frailty Aging. 2019;8(2):54\u20136.","journal-title":"J Frailty Aging"},{"key":"934_CR69","doi-asserted-by":"crossref","unstructured":"Yaghmoor F, Noorsaeed A, Alsaggaf S, Aljohani W, Scholtzova H, Boutajangout A, et al. The Role of TREM2 in Alzheimer\u2019s Disease and other neurological disorders. J Alzheimers Dis Parkinsonism. 2014;4(5).","DOI":"10.4172\/2161-0460.1000160"},{"issue":"8","key":"934_CR70","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1474-4422(18)30232-1","volume":"17","author":"S Carmona","year":"2018","unstructured":"Carmona S, Zahs K, Wu E, Dakin K, Bras J, Guerreiro R. The role of TREM2 in Alzheimer\u2019s Disease and other neurodegenerative disorders. Lancet Neurol. 2018;17(8):721\u201330.","journal-title":"Lancet Neurol"},{"issue":"1","key":"934_CR71","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13024-018-0284-2","volume":"13","author":"W Cao","year":"2018","unstructured":"Cao W, Zheng H. Peripheral immune system in aging and Alzheimer\u2019s Disease. Mol Neurodegener. 2018;13(1):51.","journal-title":"Mol Neurodegener"},{"key":"934_CR72","doi-asserted-by":"publisher","first-page":"115218","DOI":"10.1016\/j.biopha.2023.115218","volume":"165","author":"Y Li","year":"2023","unstructured":"Li Y, Xu H, Wang H, Yang K, Luan J, Wang S. TREM2: potential therapeutic targeting of microglia for Alzheimer\u2019s Disease. Biomed Pharmacother. 2023;165:115218.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"934_CR73","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s Disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"key":"934_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.brainresbull.2020.10.006","volume":"166","author":"X Cui","year":"2021","unstructured":"Cui X, Qiao J, Liu S, Wu M, Gu W. Mechanism of TREM2\/DAP12 complex affecting \u03b2-amyloid plaque deposition in Alzheimer\u2019s Disease modeled mice through mediating inflammatory response. Brain Res Bull. 2021;166:21\u20138.","journal-title":"Brain Res Bull"},{"issue":"9","key":"934_CR75","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.immuni.2023.08.008","volume":"56","author":"AP Tsai","year":"2023","unstructured":"Tsai AP, Dong C, Lin PB, Oblak AL, Di Viana G, Wang N, et al. Genetic variants of phospholipase C-\u03b32 alter the phenotype and function of microglia and confer differential risk for Alzheimer\u2019s Disease. Immunity. 2023;56(9):2121\u2013e366.","journal-title":"Immunity"},{"issue":"1","key":"934_CR76","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1152\/physrev.00042.2016","volume":"98","author":"A Verkhratsky","year":"2018","unstructured":"Verkhratsky A, Nedergaard M. Physiology of astroglia. Physiol Rev. 2018;98(1):239\u2013389.","journal-title":"Physiol Rev"},{"issue":"10","key":"934_CR77","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41583-020-0361-8","volume":"21","author":"A Semyanov","year":"2020","unstructured":"Semyanov A, Henneberger C, Agarwal A. Making sense of astrocytic calcium signals - from acquisition to interpretation. Nat Rev Neurosci. 2020;21(10):551\u201364.","journal-title":"Nat Rev Neurosci"},{"key":"934_CR78","doi-asserted-by":"crossref","unstructured":"Verkhratsky A. Astroglial calcium signaling in aging and Alzheimer\u2019s Disease. Cold Spring Harb Perspect Biol. 2019;11(7).","DOI":"10.1101\/cshperspect.a035188"},{"issue":"8","key":"934_CR79","doi-asserted-by":"publisher","first-page":"111280","DOI":"10.1016\/j.celrep.2022.111280","volume":"40","author":"D Shah","year":"2022","unstructured":"Shah D, Gsell W, Wahis J, Luckett ES, Jamoulle T, Vermaercke B, et al. Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer\u2019s Disease. Cell Rep. 2022;40(8):111280.","journal-title":"Cell Rep"},{"issue":"3","key":"934_CR80","doi-asserted-by":"publisher","first-page":"664","DOI":"10.14336\/AD.2018.0720","volume":"10","author":"K Li","year":"2019","unstructured":"Li K, Li J, Zheng J, Qin S. Reactive astrocytes in neurodegenerative Diseases. Aging Dis. 2019;10(3):664\u201375.","journal-title":"Aging Dis"},{"issue":"4","key":"934_CR81","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","volume":"18","author":"AM Arranz","year":"2019","unstructured":"Arranz AM, De Strooper B. The role of astroglia in Alzheimer\u2019s Disease: pathophysiology and clinical implications. Lancet Neurol. 2019;18(4):406\u201314.","journal-title":"Lancet Neurol"},{"key":"934_CR82","doi-asserted-by":"crossref","unstructured":"Labib D, Wang Z, Prakash P, Zimmer M, Smith MD, Frazel PW, et al. Proteomic alterations and novel markers of neurotoxic reactive astrocytes in human induced pluripotent stem cell models. 2022;1662\u20135099.","DOI":"10.3389\/fnmol.2022.870085"},{"key":"934_CR83","doi-asserted-by":"crossref","unstructured":"Smith MD, Chamling X, Gill AJ, Martinez H, Li W, Fitzgerald KC, et al. Reactive astrocytes derived from human induced pluripotent stem cells suppress oligodendrocyte precursor cell differentiation. 2022;1662\u20135099.","DOI":"10.3389\/fnmol.2022.874299"},{"issue":"2","key":"934_CR84","doi-asserted-by":"publisher","first-page":"a020420","DOI":"10.1101\/cshperspect.a020420","volume":"7","author":"MV Sofroniew","year":"2014","unstructured":"Sofroniew MV, Astrogliosis. Cold Spring Harb Perspect Biol. 2014;7(2):a020420.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"934_CR85","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/glia.24652","volume":"73","author":"\u00d6 \u0130\u015f","year":"2025","unstructured":"\u0130\u015f \u00d6, Min Y, Wang X, Oatman SR, Abraham Daniel A, Ertekin-Taner N. Multi layered omics approaches reveal glia specific alterations in Alzheimer\u2019s Disease: A systematic review and future prospects. Glia. 2025;73(3):539\u201373.","journal-title":"Glia"},{"issue":"2","key":"934_CR86","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1124\/pr.117.014647","volume":"70","author":"MA Erickson","year":"2018","unstructured":"Erickson MA, Banks WA. Neuroimmune axes of the Blood-Brain barriers and Blood-Brain interfaces: bases for physiological Regulation, Disease States, and Pharmacological interventions. Pharmacol Rev. 2018;70(2):278\u2013314.","journal-title":"Pharmacol Rev"},{"key":"934_CR87","doi-asserted-by":"crossref","unstructured":"Gupta S, Dhanda S, Sandhir R. 2-Anatomy and physiology of blood-brain barrier. In: Gao H, Gao X, editors. Brain targeted drug delivery system. Academic. 2019;7\u201331.","DOI":"10.1016\/B978-0-12-814001-7.00002-0"},{"issue":"1","key":"934_CR88","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41582-021-00578-6","volume":"18","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Victor MB, Tsai LH. Dissecting the complexities of Alzheimer Disease with in vitro models of the human brain. Nat Rev Neurol. 2022;18(1):25\u201339.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"934_CR89","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.stemcr.2020.03.011","volume":"14","author":"LE Oikari","year":"2020","unstructured":"Oikari LE, Pandit R, Stewart R, Cun\u00ed-L\u00f3pez C, Quek H, Sutharsan R, et al. Altered brain endothelial cell phenotype from a Familial Alzheimer mutation and its potential implications for amyloid clearance and drug delivery. Stem Cell Rep. 2020;14(5):924\u201339.","journal-title":"Stem Cell Rep"},{"issue":"4","key":"934_CR90","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-180098","volume":"63","author":"Z Cai","year":"2018","unstructured":"Cai Z, Qiao PF, Wan CQ, Cai M, Zhou NK, Li Q. Role of Blood-Brain barrier in Alzheimer\u2019s Disease. J Alzheimers Dis. 2018;63(4):1223\u201334.","journal-title":"J Alzheimers Dis"},{"key":"934_CR91","doi-asserted-by":"publisher","first-page":"7905486","DOI":"10.1155\/2017\/7905486","volume":"2017","author":"G Sita","year":"2017","unstructured":"Sita G, Hrelia P, Tarozzi A, Morroni F. P-glycoprotein (ABCB1) and oxidative stress: focus on Alzheimer\u2019s Disease. Oxid Med Cell Longev. 2017;2017:7905486.","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"934_CR92","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20171406","volume":"214","author":"A Montagne","year":"2017","unstructured":"Montagne A, Zhao Z, Zlokovic BV. Alzheimer\u2019s Disease: A matter of blood-brain barrier dysfunction? J Exp Med. 2017;214(11):3151\u201369.","journal-title":"J Exp Med"},{"issue":"5","key":"934_CR93","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ana.23648","volume":"72","author":"R Daneman","year":"2012","unstructured":"Daneman R. The blood-brain barrier in health and Disease. Ann Neurol. 2012;72(5):648\u201372.","journal-title":"Ann Neurol"},{"issue":"7","key":"934_CR94","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1021\/acschemneuro.0c00719","volume":"12","author":"A Sait","year":"2021","unstructured":"Sait A, Angeli C, Doig AJ, Day PJR. Viral involvement in Alzheimer\u2019s Disease. ACS Chem Neurosci. 2021;12(7):1049\u201360.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"934_CR95","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/alz.13414","volume":"20","author":"M Tejeda","year":"2024","unstructured":"Tejeda M, Farrell J, Zhu C, Wetzler L, Lunetta KL, Bush WS, et al. DNA from multiple viral species is associated with Alzheimer\u2019s Disease risk. Alzheimers Dement. 2024;20(1):253\u201365.","journal-title":"Alzheimers Dement"},{"key":"934_CR96","doi-asserted-by":"crossref","unstructured":"Griggs E, Trageser K, Naughton S, Yang EJ, Mathew B, Van Hyfte G, et al. Recapitulation of pathophysiological features of AD in SARS-CoV-2-infected subjects. Elife. 2023;12.","DOI":"10.7554\/eLife.86333"},{"key":"934_CR97","doi-asserted-by":"publisher","first-page":"1125109","DOI":"10.3389\/fncel.2023.1125109","volume":"17","author":"H Hern\u00e1ndez-Parra","year":"2023","unstructured":"Hern\u00e1ndez-Parra H, Reyes-Hern\u00e1ndez OD, Figueroa-Gonz\u00e1lez G, Gonz\u00e1lez-Del Carmen M, Gonz\u00e1lez-Torres M, Pe\u00f1a-Corona SI, et al. Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain. Front Cell Neurosci. 2023;17:1125109.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"934_CR98","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MOH.0000000000000368","volume":"24","author":"HJ Ahn","year":"2017","unstructured":"Ahn HJ, Chen ZL, Zamolodchikov D, Norris EH, Strickland S. Interactions of beta-amyloid peptide with fibrinogen and coagulation factor XII May contribute to Alzheimer\u2019s Disease. Curr Opin Hematol. 2017;24(5):427\u201331.","journal-title":"Curr Opin Hematol"},{"key":"934_CR99","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3389\/fimmu.2018.01066","volume":"9","author":"I Strominger","year":"2018","unstructured":"Strominger I, Elyahu Y, Berner O, Reckhow J, Mittal K, Nemirovsky A, et al. The choroid plexus functions as a niche for T-Cell stimulation within the central nervous system. Front Immunol. 2018;9:1066.","journal-title":"Front Immunol"},{"issue":"6","key":"934_CR100","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2174\/1871527319666200812223007","volume":"19","author":"H Wang","year":"2020","unstructured":"Wang H, Huang L, Wu L, Lan J, Feng X, Li P, et al. The MMP-2\/TIMP-2 system in Alzheimer Disease. CNS Neurol Disord Drug Targets. 2020;19(6):402\u201316.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"934_CR101","doi-asserted-by":"publisher","first-page":"652111","DOI":"10.3389\/fncel.2021.652111","volume":"15","author":"J Lutshumba","year":"2021","unstructured":"Lutshumba J, Nikolajczyk BS, Bachstetter AD. Dysregulation of systemic immunity in aging and dementia. Front Cell Neurosci. 2021;15:652111.","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"934_CR102","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","volume":"17","author":"BM Bettcher","year":"2021","unstructured":"Bettcher BM, Tansey MG, Dorothee G, Heneka MT. Peripheral and central immune system crosstalk in Alzheimer Disease - a research prospectus. Nat Rev Neurol. 2021;17(11):689\u2013701.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"934_CR103","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1038\/s41467-024-48926-6","volume":"15","author":"\u00d6 \u0130\u015f","year":"2024","unstructured":"\u0130\u015f \u00d6, Wang X, Reddy JS, Min Y, Yilmaz E, Bhattarai P, et al. Gliovascular transcriptional perturbations in Alzheimer\u2019s Disease reveal molecular mechanisms of blood brain barrier dysfunction. Nat Commun. 2024;15(1):4758.","journal-title":"Nat Commun"},{"key":"934_CR104","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s Disease. Redox Biol. 2018;14:450\u201364.","journal-title":"Redox Biol"},{"issue":"658","key":"934_CR105","doi-asserted-by":"publisher","first-page":"eabk1051","DOI":"10.1126\/scitranslmed.abk1051","volume":"14","author":"AV Venkataraman","year":"2022","unstructured":"Venkataraman AV, Mansur A, Rizzo G, Bishop C, Lewis Y, Kocagoncu E, et al. Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer\u2019s Disease. Sci Transl Med. 2022;14(658):eabk1051.","journal-title":"Sci Transl Med"},{"key":"934_CR106","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12944-016-0288-2","volume":"15","author":"J Dose","year":"2016","unstructured":"Dose J, Huebbe P, Nebel A, Rimbach G. APOE genotype and stress response - a mini review. Lipids Health Dis. 2016;15:121.","journal-title":"Lipids Health Dis"},{"issue":"10","key":"934_CR107","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1039\/C6MT00150E","volume":"8","author":"C Cheignon","year":"2016","unstructured":"Cheignon C, Faller P, Testemale D, Hureau C, Collin F. Metal-catalyzed oxidation of A\u03b2 and the resulting reorganization of Cu binding sites promote ROS production. Metallomics. 2016;8(10):1081\u20139.","journal-title":"Metallomics"},{"issue":"5","key":"934_CR108","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3892\/br.2016.630","volume":"4","author":"WJ Huang","year":"2016","unstructured":"Huang WJ, Zhang X, Chen WW. Role of oxidative stress in Alzheimer\u2019s Disease. Biomed Rep. 2016;4(5):519\u201322.","journal-title":"Biomed Rep"},{"issue":"3","key":"934_CR109","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3233\/JAD-210497","volume":"83","author":"F Cioffi","year":"2021","unstructured":"Cioffi F, Adam RHI, Bansal R, Broersen K. A review of oxidative stress products and related genes in early Alzheimer\u2019s Disease. J Alzheimers Dis. 2021;83(3):977\u20131001.","journal-title":"J Alzheimers Dis"},{"key":"934_CR110","doi-asserted-by":"publisher","first-page":"182303","DOI":"10.1155\/2014\/182303","volume":"2014","author":"YT Chang","year":"2014","unstructured":"Chang YT, Chang WN, Tsai NW, Huang CC, Kung CT, Su YJ, et al. The roles of biomarkers of oxidative stress and antioxidant in Alzheimer\u2019s Disease: a systematic review. Biomed Res Int. 2014;2014:182303.","journal-title":"Biomed Res Int"},{"issue":"9","key":"934_CR111","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.4103\/1673-5374.367843","volume":"18","author":"C Sharma","year":"2023","unstructured":"Sharma C, Kim SR. Oxidative stress: culprit or consequence in Alzheimer\u2019s amyloidopathy. Neural Regen Res. 2023;18(9):1948\u20139.","journal-title":"Neural Regen Res"},{"key":"934_CR112","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/bs.pmbts.2016.12.017","volume":"146","author":"RH Swerdlow","year":"2017","unstructured":"Swerdlow RH, Koppel S, Weidling I, Hayley C, Ji Y, Wilkins HM. Mitochondria, Cybrids, Aging, and Alzheimer\u2019s Disease. Prog Mol Biol Transl Sci. 2017;146:259\u2013302.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"8","key":"934_CR113","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/alz.12119","volume":"16","author":"RH Swerdlow","year":"2020","unstructured":"Swerdlow RH, Hui D, Chalise P, Sharma P, Wang X, Andrews SJ, et al. Exploratory analysis of MtDNA haplogroups in two Alzheimer\u2019s longitudinal cohorts. Alzheimers Dement. 2020;16(8):1164\u201372.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"934_CR114","doi-asserted-by":"publisher","first-page":"8294","DOI":"10.1002\/alz.14249","volume":"20","author":"R Batra","year":"2024","unstructured":"Batra R, Krumsiek J, Wang X, Allen M, Blach C, Kastenm\u00fcller G, et al. Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer\u2019s Disease and progressive supranuclear palsy. Alzheimers Dement. 2024;20(12):8294\u2013307.","journal-title":"Alzheimers Dement"},{"key":"934_CR115","doi-asserted-by":"crossref","unstructured":"Wang X, Allen M, \u0130\u015f \u00d6, Reddy JS, Tutor-New FQ, Castanedes Casey M, et al. Alzheimer\u2019s Disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions. J Clin Invest. 2022;132(2).","DOI":"10.1172\/JCI149904"},{"issue":"18","key":"934_CR116","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1212\/WNL.0000000000010869","volume":"95","author":"M Bilgel","year":"2020","unstructured":"Bilgel M, Bischof GN. Early role of iron in modulating amyloid\u2019s association with neurodegeneration. Neurology. 2020;95(18):809\u201310.","journal-title":"Neurology"},{"issue":"19","key":"934_CR117","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.ccr.2012.03.013","volume":"256","author":"H Kozlowski","year":"2012","unstructured":"Kozlowski H, Luczkowski M, Remelli M, Valensin D. Copper, zinc and iron in neurodegenerative Diseases (Alzheimer\u2019s, parkinson\u2019s and prion Diseases). Coord Chem Rev. 2012;256(19):2129\u201341.","journal-title":"Coord Chem Rev"},{"key":"934_CR118","doi-asserted-by":"publisher","first-page":"104795","DOI":"10.1016\/j.nbd.2020.104795","volume":"138","author":"DA Butterfield","year":"2020","unstructured":"Butterfield DA, Mattson MP. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer\u2019s Disease. Neurobiol Dis. 2020;138:104795.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"934_CR119","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/jnc.14471","volume":"147","author":"M Audano","year":"2018","unstructured":"Audano M, Schneider A, Mitro N. Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration. J Neurochem. 2018;147(3):291\u2013309.","journal-title":"J Neurochem"},{"issue":"1","key":"934_CR120","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12944-019-0965-z","volume":"18","author":"G Hussain","year":"2019","unstructured":"Hussain G, Wang J, Rasul A, Anwar H, Imran A, Qasim M, et al. Role of cholesterol and sphingolipids in brain development and neurological Diseases. Lipids Health Dis. 2019;18(1):26.","journal-title":"Lipids Health Dis"},{"key":"934_CR121","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3389\/fphys.2020.00598","volume":"11","author":"H Chew","year":"2020","unstructured":"Chew H, Solomon VA, Fonteh AN. Involvement of lipids in Alzheimer\u2019s Disease pathology and potential therapies. Front Physiol. 2020;11:598.","journal-title":"Front Physiol"},{"key":"934_CR122","doi-asserted-by":"crossref","unstructured":"Chung J, Phukan G, Vergote D, Mohamed A, Maulik M, Stahn M, et al. Endosomal-lysosomal cholesterol sequestration by U18666A differentially regulates amyloid precursor protein (APP) metabolism in normal and app-overexpressing cells. Mol Cell Biol. 2018;38(11).","DOI":"10.1128\/MCB.00529-17"},{"issue":"11","key":"934_CR123","first-page":"739","volume":"42","author":"W Jeong","year":"2019","unstructured":"Jeong W, Lee H, Cho S, Seo J. ApoE4-Induced cholesterol dysregulation and its brain cell Type-Specific implications in the pathogenesis of Alzheimer\u2019s Disease. Mol Cells. 2019;42(11):739\u201346.","journal-title":"Mol Cells"},{"key":"934_CR124","doi-asserted-by":"crossref","unstructured":"Husain MA, Laurent B, Plourde M. APOE and Alzheimer\u2019s Disease: from lipid transport to physiopathology and therapeutics. Front Neuro 1. 2021;15.","DOI":"10.3389\/fnins.2021.630502"},{"issue":"1","key":"934_CR125","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12916-019-1299-4","volume":"17","author":"M Safieh","year":"2019","unstructured":"Safieh M, Korczyn AD, Michaelson DM. ApoE4: an emerging therapeutic target for Alzheimer\u2019s Disease. BMC Med. 2019;17(1):64.","journal-title":"BMC Med"},{"key":"934_CR126","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","volume":"6","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Bu G. The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s Disease. Front Aging Neurosci. 2014;6:93.","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"934_CR127","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/alz.12501","volume":"17","author":"A Haeger","year":"2021","unstructured":"Haeger A, Bottlaender M, Lagarde J, Porciuncula Baptista R, Rabrait-Lerman C, Luecken V, et al. What can 7T sodium MRI tell Us about cellular energy depletion and neurotransmission in Alzheimer\u2019s Disease? Alzheimers Dement. 2021;17(11):1843\u201354.","journal-title":"Alzheimers Dement"},{"key":"934_CR128","doi-asserted-by":"crossref","unstructured":"Kim JP, Nho K, Wang T, Huynh K, Arnold M, Risacher SL, et al. Circulating lipid profiles are associated with cross-sectional and longitudinal changes of central biomarkers for Alzheimer\u2019s Disease. MedRxiv. 2023.","DOI":"10.1101\/2023.06.12.23291054"},{"key":"934_CR129","doi-asserted-by":"crossref","unstructured":"Poitelon Y, Kopec AM, Belin S. Myelin fat facts: an overview of lipids and fatty acid metabolism. Cells. 2020;9(4).","DOI":"10.3390\/cells9040812"},{"key":"934_CR130","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-981-13-9913-8_12","volume":"1175","author":"AM Butt","year":"2019","unstructured":"Butt AM, De La Rocha IC, Rivera A. Oligodendroglial cells in Alzheimer\u2019s Disease. Adv Exp Med Biol. 2019;1175:325\u201333.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"934_CR131","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-024-00760-6","volume":"19","author":"SL Rossi","year":"2024","unstructured":"Rossi SL, Bovenkamp DE. Are oligodendrocytes the missing link in Alzheimer\u2019s Disease and related dementia research? Mol Neurodegener. 2024;19(1):84.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"934_CR132","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-009-0601-5","volume":"119","author":"M Bradl","year":"2010","unstructured":"Bradl M, Lassmann H. Oligodendrocytes: biology and pathology. Acta Neuropathol. 2010;119(1):37\u201353.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"934_CR133","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamaneurol.2016.3232","volume":"74","author":"DC Dean","year":"2017","unstructured":"Dean DC 3rd, Hurley SA, Kecskemeti SR, O\u2019Grady JP, Canda C, Davenport-Sis NJ, et al. Association of amyloid pathology with Myelin alteration in preclinical Alzheimer Disease. JAMA Neurol. 2017;74(1):41\u20139.","journal-title":"JAMA Neurol"},{"issue":"1","key":"934_CR134","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer\u2019s Disease: a focus on Myelin and oligodendrocytes. Acta Neuropathol Commun. 2018;6(1):22.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"934_CR135","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40035-022-00321-1","volume":"11","author":"LR Hirschfeld","year":"2022","unstructured":"Hirschfeld LR, Risacher SL, Nho K, Saykin AJ. Myelin repair in Alzheimer\u2019s Disease: a review of biological pathways and potential therapeutics. Transl Neurodegener. 2022;11(1):47.","journal-title":"Transl Neurodegener"},{"key":"934_CR136","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neurobiolaging.2020.05.016","volume":"94","author":"I Vanzulli","year":"2020","unstructured":"Vanzulli I, Papanikolaou M, De-La-Rocha IC, Pieropan F, Rivera AD, Gomez-Nicola D, et al. Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple Transgenic mouse model of Alzheimer\u2019s Disease. Neurobiol Aging. 2020;94:130\u20139.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"934_CR137","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41598-017-18744-6","volume":"8","author":"D Espinosa-Hoyos","year":"2018","unstructured":"Espinosa-Hoyos D, Jagielska A, Homan KA, Du H, Busbee T, Anderson DG, et al. Engineered 3D-printed artificial axons. Sci Rep. 2018;8(1):478.","journal-title":"Sci Rep"},{"issue":"7761","key":"934_CR138","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, et al. Single-cell transcriptomic analysis of Alzheimer\u2019s Disease. Nature. 2019;570(7761):332\u20137.","journal-title":"Nature"},{"issue":"3","key":"934_CR139","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jalz.2017.09.012","volume":"14","author":"M Allen","year":"2018","unstructured":"Allen M, Wang X, Burgess JD, Watzlawik J, Serie DJ, Younkin CS, et al. Conserved brain myelination networks are altered in Alzheimer\u2019s and other neurodegenerative Diseases. Alzheimers Dement. 2018;14(3):352\u201366.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"934_CR140","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13024-020-00392-6","volume":"15","author":"X Wang","year":"2020","unstructured":"Wang X, Allen M, Li S, Quicksall ZS, Patel TA, Carnwath TP, et al. Deciphering cellular transcriptional alterations in Alzheimer\u2019s Disease brains. Mol Neurodegener. 2020;15(1):38.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"934_CR141","doi-asserted-by":"publisher","first-page":"RC118","DOI":"10.1523\/JNEUROSCI.21-01-j0001.2001","volume":"21","author":"J Xu","year":"2001","unstructured":"Xu J, Chen S, Ahmed SH, Chen H, Ku G, Goldberg MP, et al. Amyloid-beta peptides are cytotoxic to oligodendrocytes. J Neurosci. 2001;21(1):RC118.","journal-title":"J Neurosci"},{"issue":"2","key":"934_CR142","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/cne.10714","volume":"462","author":"L Marner","year":"2003","unstructured":"Marner L, Nyengaard JR, Tang Y, Pakkenberg B. Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol. 2003;462(2):144\u201352.","journal-title":"J Comp Neurol"},{"issue":"8","key":"934_CR143","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.neurobiolaging.2009.08.007","volume":"32","author":"G Bartzokis","year":"2011","unstructured":"Bartzokis G. Alzheimer\u2019s Disease as homeostatic responses to age-related Myelin breakdown. Neurobiol Aging. 2011;32(8):1341\u201371.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"934_CR144","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00401-017-1738-2","volume":"134","author":"KE McAleese","year":"2017","unstructured":"McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, et al. Parietal white matter lesions in Alzheimer\u2019s Disease are associated with cortical neurodegenerative pathology, but not with small vessel Disease. Acta Neuropathol. 2017;134(3):459\u201373.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"934_CR145","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3233\/JAD-161118","volume":"57","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla R, Reddy PH. Therapeutics of neurotransmitters in Alzheimer\u2019s Disease. J Alzheimers Dis. 2017;57(4):1049\u201369.","journal-title":"J Alzheimers Dis"},{"key":"934_CR146","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.brainres.2017.06.023","volume":"1670","author":"G Pepeu","year":"2017","unstructured":"Pepeu G, Grazia Giovannini M. The fate of the brain cholinergic neurons in neurodegenerative Diseases. Brain Res. 2017;1670:173\u201384.","journal-title":"Brain Res"},{"issue":"2","key":"934_CR147","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.bbr.2009.12.046","volume":"221","author":"NJ Woolf","year":"2011","unstructured":"Woolf NJ, Butcher LL. Cholinergic systems mediate action from movement to higher consciousness. Behav Brain Res. 2011;221(2):488\u201398.","journal-title":"Behav Brain Res"},{"issue":"1","key":"934_CR148","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","volume":"14","author":"TH Ferreira-Vieira","year":"2016","unstructured":"Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer\u2019s Disease: targeting the cholinergic system. Curr Neuropharmacol. 2016;14(1):101\u201315.","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"934_CR149","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.410100203","volume":"10","author":"PJ Whitehouse","year":"1981","unstructured":"Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer Disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol. 1981;10(2):122\u20136.","journal-title":"Ann Neurol"},{"issue":"7","key":"934_CR150","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1073\/pnas.87.7.2452","volume":"87","author":"TA Slotkin","year":"1990","unstructured":"Slotkin TA, Seidler FJ, Crain BJ, Bell JM, Bissette G, Nemeroff CB. Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer Disease: implications for etiology and therapy. Proc Natl Acad Sci U S A. 1990;87(7):2452\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"934_CR151","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s Disease. Brain. 2018;141(7):1917\u201333.","journal-title":"Brain"},{"issue":"1","key":"934_CR152","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","volume":"27","author":"LK Huang","year":"2020","unstructured":"Huang LK, Chao SP, Hu CJ. Clinical trials of new drugs for Alzheimer Disease. J Biomed Sci. 2020;27(1):18.","journal-title":"J Biomed Sci"},{"issue":"Suppl 3","key":"934_CR153","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/00002093-199404000-00005","volume":"8","author":"MA Raskind","year":"1994","unstructured":"Raskind MA, Peskind ER. Neurobiologic bases of noncognitive behavioral problems in Alzheimer Disease. Alzheimer Dis Assoc Disord. 1994;8(Suppl 3):54\u201360.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"934_CR154","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: A prospective cohort study. JAMA Intern Med. 2015;175(3):401\u20137.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"934_CR155","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jamaneurol.2016.0580","volume":"73","author":"SL Risacher","year":"2016","unstructured":"Risacher SL, McDonald BC, Tallman EF, West JD, Farlow MR, Unverzagt FW, et al. Association between anticholinergic medication use and Cognition, brain Metabolism, and brain atrophy in cognitively normal older adults. JAMA Neurol. 2016;73(6):721\u201332.","journal-title":"JAMA Neurol"},{"issue":"Pt 6","key":"934_CR156","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/brain\/awv024","volume":"138","author":"A Baker-Nigh","year":"2015","unstructured":"Baker-Nigh A, Vahedi S, Davis EG, Weintraub S, Bigio EH, Klein WL, et al. Neuronal amyloid-\u03b2 accumulation within cholinergic basal forebrain in ageing and Alzheimer\u2019s Disease. Brain. 2015;138(Pt 6):1722\u201337.","journal-title":"Brain"},{"issue":"3","key":"934_CR157","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/mp.2013.19","volume":"19","author":"VK Ramanan","year":"2014","unstructured":"Ramanan VK, Risacher SL, Nho K, Kim S, Swaminathan S, Shen L, et al. APOE and BCHE as modulators of cerebral amyloid deposition: a Florbetapir PET genome-wide association study. Mol Psychiatry. 2014;19(3):351\u20137.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"934_CR158","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2165\/11590190-000000000-00000","volume":"25","author":"WJ Van der Geldenhuys","year":"2011","unstructured":"Van der Geldenhuys WJ. Role of serotonin in Alzheimer\u2019s Disease: a new therapeutic target? CNS Drugs. 2011;25(9):765\u201381.","journal-title":"CNS Drugs"},{"issue":"7","key":"934_CR159","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s40265-014-0217-5","volume":"74","author":"MJ Ramirez","year":"2014","unstructured":"Ramirez MJ, Lai MK, Tordera RM, Francis PT. Serotonergic therapies for cognitive symptoms in Alzheimer\u2019s Disease: rationale and current status. Drugs. 2014;74(7):729\u201336.","journal-title":"Drugs"},{"issue":"7","key":"934_CR160","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1002\/hbm.23595","volume":"38","author":"FS Barrett","year":"2017","unstructured":"Barrett FS, Workman CI, Sair HI, Savonenko AV, Kraut MA, Sodums DJ, et al. Association between serotonin denervation and resting-state functional connectivity in mild cognitive impairment. Hum Brain Mapp. 2017;38(7):3391\u2013401.","journal-title":"Hum Brain Mapp"},{"key":"934_CR161","doi-asserted-by":"publisher","first-page":"239821281875709","DOI":"10.1177\/2398212818757098","volume":"2","author":"AS Mitchell","year":"2018","unstructured":"Mitchell AS, Czajkowski R, Zhang N, Jeffery K, Nelson AJD. Retrosplenial cortex and its role in Spatial cognition. Brain Neurosci Adv. 2018;2:2398212818757098.","journal-title":"Brain Neurosci Adv"},{"issue":"36","key":"934_CR162","doi-asserted-by":"publisher","first-page":"14968","DOI":"10.1073\/pnas.1107411108","volume":"108","author":"JR Cirrito","year":"2011","unstructured":"Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, Sathyan A, et al. Serotonin signaling is associated with lower amyloid-\u03b2 levels and plaques in Transgenic mice and humans. Proc Natl Acad Sci U S A. 2011;108(36):14968\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"236","key":"934_CR163","doi-asserted-by":"publisher","first-page":"236re4","DOI":"10.1126\/scitranslmed.3008169","volume":"6","author":"YI Sheline","year":"2014","unstructured":"Sheline YI, West T, Yarasheski K, Swarm R, Jasielec MS, Fisher JR, et al. An antidepressant decreases CSF A\u03b2 production in healthy individuals and in Transgenic AD mice. Sci Transl Med. 2014;6(236):236re4.","journal-title":"Sci Transl Med"},{"issue":"3","key":"934_CR164","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1176\/appi.ajp.2017.17040404","volume":"175","author":"C Bartels","year":"2018","unstructured":"Bartels C, Wagner M, Wolfsgruber S, Ehrenreich H, Schneider A. Impact of SSRI therapy on risk of conversion from mild cognitive impairment to Alzheimer\u2019s dementia in individuals with previous depression. Am J Psychiatry. 2018;175(3):232\u201341.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"934_CR165","doi-asserted-by":"publisher","first-page":"e14579","DOI":"10.1002\/alz.14579","volume":"21","author":"DJ Terstege","year":"2025","unstructured":"Terstege DJ, Jabeen S, Galea LAM, Epp JR, Sargin D. SSRIs reduce plasma Tau and restore dorsal Raphe metabolism in Alzheimer\u2019s Disease. Alzheimers Dement. 2025;21(2):e14579.","journal-title":"Alzheimers Dement"},{"key":"934_CR166","doi-asserted-by":"crossref","unstructured":"Yuede CM, Wallace CE, Davis TA, Gardiner WD, Hettinger JC, Edwards HM, et al. Pimavanserin, a 5HT(2A) receptor inverse agonist, rapidly suppresses A\u03b2 production and related pathology in a mouse model of Alzheimer\u2019s Disease. J Neurochem. 2020.","DOI":"10.1111\/jnc.15260"},{"issue":"1","key":"934_CR167","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-016-0112-5","volume":"11","author":"JR Fisher","year":"2016","unstructured":"Fisher JR, Wallace CE, Tripoli DL, Sheline YI, Cirrito JR. Redundant Gs-coupled serotonin receptors regulate amyloid-\u03b2 metabolism in vivo. Mol Neurodegener. 2016;11(1):45.","journal-title":"Mol Neurodegener"},{"key":"934_CR168","doi-asserted-by":"crossref","unstructured":"Gr\u00fcnder G, Cumming P. Serotonin and amyloid deposition: a link between depression and Alzheimer\u2019s Disease? an editorial highlight on pimavanserin, a 5HT(2A) receptor inverse agonist, rapidly suppresses A\u03b2 production and related pathology in a mouse model of Alzheimer\u2019s Disease. J Neurochem. 2021.","DOI":"10.1111\/jnc.15269"},{"key":"934_CR169","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainres.2018.01.001","volume":"1702","author":"M Gannon","year":"2019","unstructured":"Gannon M, Wang Q. Complex noradrenergic dysfunction in Alzheimer\u2019s Disease: low norepinephrine input is not always to blame. Brain Res. 2019;1702:12\u20136.","journal-title":"Brain Res"},{"key":"934_CR170","doi-asserted-by":"crossref","unstructured":"Zhang F, Gannon M, Chen Y, Yan S, Zhang S, Feng W, et al. beta-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3beta\/tau cascade. Sci Transl Med. 2020;12(526).","DOI":"10.1126\/scitranslmed.aay6931"},{"issue":"5","key":"934_CR171","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s43587-024-00626-y","volume":"4","author":"E Bueichek\u00fa","year":"2024","unstructured":"Bueichek\u00fa E, Diez I, Kim CM, Becker JA, Koops EA, Kwong K, et al. Spatiotemporal patterns of locus coeruleus integrity predict cortical Tau and cognition. Nat Aging. 2024;4(5):625\u201337.","journal-title":"Nat Aging"},{"issue":"4","key":"934_CR172","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH. Role of glutamate and NMDA receptors in Alzheimer\u2019s Disease. J Alzheimers Dis. 2017;57(4):1041\u20138.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"934_CR173","doi-asserted-by":"publisher","first-page":"36","DOI":"10.37349\/ent.2022.00017","volume":"2","author":"T Glaser","year":"2022","unstructured":"Glaser T, Silva JB, Juvenal GA, Maiolini PN, Turrini N, Petiz LL, et al. Various facets of excitotoxicity. Explor Neuroprotective Therapy. 2022;2(1):36\u201364.","journal-title":"Explor Neuroprotective Therapy"},{"issue":"21","key":"934_CR174","first-page":"2003","volume":"8","author":"C Guo","year":"2013","unstructured":"Guo C, Sun L, Chen X, Zhang D. Oxidative stress, mitochondrial damage and neurodegenerative Diseases. Neural Regen Res. 2013;8(21):2003\u201314.","journal-title":"Neural Regen Res"},{"issue":"1","key":"934_CR175","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1503\/jpn.110190","volume":"38","author":"TJ Revett","year":"2013","unstructured":"Revett TJ, Baker GB, Jhamandas J, Kar S. Glutamate system, amyloid \u00df peptides and Tau protein: functional interrelationships and relevance to Alzheimer Disease pathology. J Psychiatry Neurosci. 2013;38(1):6\u201323.","journal-title":"J Psychiatry Neurosci"},{"issue":"6","key":"934_CR176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.1037","volume":"86","author":"H Tu","year":"2025","unstructured":"Tu H, Zhou S, Lin J. Combined effects of donepezil and memantine on behavioral and psychological Symptoms, cognitive Function, and daily living abilities in patients with Alzheimer\u2019s Disease. Br J Hosp Med (Lond). 2025;86(6):1\u201315.","journal-title":"Br J Hosp Med (Lond)"},{"issue":"3","key":"934_CR177","first-page":"Cd003154","volume":"3","author":"R McShane","year":"2019","unstructured":"McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, et al. Memantine for dementia. Cochrane Database Syst Rev. 2019;3(3):Cd003154.","journal-title":"Cochrane Database Syst Rev"},{"key":"934_CR178","doi-asserted-by":"crossref","unstructured":"Govindpani K, Calvo-Flores Guzman B, Vinnakota C, Waldvogel HJ, Faull RL, Kwakowsky A. Towards a better understanding of GABAergic remodeling in Alzheimer\u2019s Disease. Int J Mol Sci. 2017;18(8).","DOI":"10.3390\/ijms18081813"},{"key":"934_CR179","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.brainres.2018.11.042","volume":"1707","author":"E Ambrad Giovannetti","year":"2019","unstructured":"Ambrad Giovannetti E, Fuhrmann M. Unsupervised excitation: GABAergic dysfunctions in Alzheimer\u2019s Disease. Brain Res. 2019;1707:216\u201326.","journal-title":"Brain Res"},{"issue":"1","key":"934_CR180","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neuron.2016.08.034","volume":"92","author":"LC Schmid","year":"2016","unstructured":"Schmid LC, Mittag M, Poll S, Steffen J, Wagner J, Geis HR, et al. Dysfunction of Somatostatin-Positive interneurons associated with memory deficits in an Alzheimer\u2019s Disease model. Neuron. 2016;92(1):114\u201325.","journal-title":"Neuron"},{"key":"934_CR181","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bbi.2023.03.002","volume":"110","author":"AML Osse","year":"2023","unstructured":"Osse AML, Pandey RS, Wirt RA, Ortiz AA, Salazar A, Kimmich M, et al. Reduction in GABAB on glia induce Alzheimer\u2019s Disease related changes. Brain Behav Immun. 2023;110:260\u201375.","journal-title":"Brain Behav Immun"},{"issue":"10","key":"934_CR182","first-page":"e30195","volume":"14","author":"M Purushotham","year":"2022","unstructured":"Purushotham M, Tashrifwala F, Jena R, Vudugula SA, Patil RS, Agrawal A. The association between Alzheimer\u2019s Disease and epilepsy: A narrative review. Cureus. 2022;14(10):e30195.","journal-title":"Cureus"},{"key":"934_CR183","doi-asserted-by":"publisher","first-page":"102069","DOI":"10.1016\/j.jchemneu.2021.102069","volume":"120","author":"HS Nandini","year":"2022","unstructured":"Nandini HS, Krishna KL, Apattira C. Combination of ocimum sanctum extract and Levetiracetam ameliorates cognitive dysfunction and hippocampal architecture in rat model of Alzheimer\u2019s Disease. J Chem Neuroanat. 2022;120:102069.","journal-title":"J Chem Neuroanat"},{"key":"934_CR184","doi-asserted-by":"crossref","unstructured":"Xiao MF, Xu D, Craig MT, Pelkey KA, Chien CC, Shi Y, et al. NPTX2 and cognitive dysfunction in Alzheimer\u2019s Disease. Elife. 2017;6.","DOI":"10.7554\/eLife.23798"},{"issue":"12","key":"934_CR185","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/alz.12353","volume":"17","author":"O Libiger","year":"2021","unstructured":"Libiger O, Shaw LM, Watson MH, Nairn AC, Uma\u00f1a KL, Biarnes MC, et al. Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer\u2019s Disease. Alzheimers Dement. 2021;17(12):1976\u201387.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"934_CR186","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13024-020-00398-0","volume":"15","author":"O Belbin","year":"2020","unstructured":"Belbin O, Xiao MF, Xu D, Carmona-Iragui M, Pegueroles J, Benejam B, et al. Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer\u2019s Disease-related inhibitory circuit dysfunction in adults with down syndrome. Mol Neurodegener. 2020;15(1):46.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"934_CR187","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/09727531231187235","volume":"31","author":"H Fatima","year":"2024","unstructured":"Fatima H, Rangwala HS, Riaz F, Rangwala BS, Siddiq MA. Breakthroughs in Alzheimer\u2019s research: A path to a more promising future? Ann Neurosci. 2024;31(1):63\u201370.","journal-title":"Ann Neurosci"},{"issue":"4","key":"934_CR188","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/ana.26725","volume":"94","author":"A Soldan","year":"2023","unstructured":"Soldan A, Oh S, Ryu T, Pettigrew C, Zhu Y, Moghekar A, et al. NPTX2 in cerebrospinal fluid predicts the progression from normal cognition to mild cognitive impairment. Ann Neurol. 2023;94(4):620\u201331.","journal-title":"Ann Neurol"},{"key":"934_CR189","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.trci.2019.11.002","volume":"5","author":"D Galasko","year":"2019","unstructured":"Galasko D, Xiao M, Xu D, Smirnov D, Salmon DP, Dewit N, et al. Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer\u2019s Disease. Alzheimers Dement (N Y). 2019;5:871\u201382.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"689","key":"934_CR190","doi-asserted-by":"publisher","first-page":"eadf0141","DOI":"10.1126\/scitranslmed.adf0141","volume":"15","author":"J Zhou","year":"2023","unstructured":"Zhou J, Wade SD, Graykowski D, Xiao MF, Zhao B, Giannini LAA, et al. The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Sci Transl Med. 2023;15(689):eadf0141.","journal-title":"Sci Transl Med"},{"issue":"7","key":"934_CR191","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/alz.12097","volume":"16","author":"AP Mecca","year":"2020","unstructured":"Mecca AP, Chen MK, O\u2019Dell RS, Naganawa M, Toyonaga T, Godek TA, et al. In vivo measurement of widespread synaptic loss in Alzheimer\u2019s Disease with SV2A PET. Alzheimers Dement. 2020;16(7):974\u201382.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"934_CR192","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/alz.12582","volume":"18","author":"AP Mecca","year":"2022","unstructured":"Mecca AP, O\u2019Dell RS, Sharp ES, Banks ER, Bartlett HH, Zhao W, et al. Synaptic density and cognitive performance in Alzheimer\u2019s Disease: A PET imaging study with [(11) C]UCB-J. Alzheimers Dement. 2022;18(12):2527\u201336.","journal-title":"Alzheimers Dement"},{"issue":"23","key":"934_CR193","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1523\/JNEUROSCI.0169-23.2023","volume":"43","author":"A Medina-Samam\u00e9","year":"2023","unstructured":"Medina-Samam\u00e9 A, Paller \u00c9, Bril MR, Archvadze A, Sim\u00f5es-Abade MBC, Esta\u00f1ol-Cayuela P, et al. Role of neurexins in Alzheimer\u2019s Disease. J Neurosci. 2023;43(23):4194\u20136.","journal-title":"J Neurosci"},{"issue":"10","key":"934_CR194","doi-asserted-by":"publisher","first-page":"210091","DOI":"10.1098\/rsob.210091","volume":"11","author":"K Cuttler","year":"2021","unstructured":"Cuttler K, Hassan M, Carr J, Cloete R, Bardien S. Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders. Open Biol. 2021;11(10):210091.","journal-title":"Open Biol"},{"key":"934_CR195","doi-asserted-by":"publisher","first-page":"969547","DOI":"10.3389\/fcell.2022.969547","volume":"10","author":"G Pfundstein","year":"2022","unstructured":"Pfundstein G, Nikonenko AG, Sytnyk V. Amyloid precursor protein (APP) and amyloid \u03b2 (A\u03b2) interact with cell adhesion molecules: implications in Alzheimer\u2019s Disease and normal physiology. Front Cell Dev Biol. 2022;10:969547.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"934_CR196","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41582-025-01094-7","volume":"21","author":"RN Taddei","year":"2025","unstructured":"Taddei RN, Duff KE. Synapse vulnerability and resilience across the clinical spectrum of dementias. Nat Rev Neurol. 2025;21(7):353\u201369.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"934_CR197","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mcn.2012.03.004","volume":"50","author":"M Hruska","year":"2012","unstructured":"Hruska M, Dalva MB. Ephrin regulation of synapse formation, function and plasticity. Mol Cell Neurosci. 2012;50(1):35\u201344.","journal-title":"Mol Cell Neurosci"},{"key":"934_CR198","doi-asserted-by":"crossref","unstructured":"Matsumoto M, Gomez-Soler M, Lombardi S, Lechtenberg BC, Pasquale EB. Missense mutations of the ephrin receptor EPHA1 associated with Alzheimer\u2019s Disease disrupt receptor signaling functions. J Biol Chem. 2024:108099.","DOI":"10.1016\/j.jbc.2024.108099"},{"issue":"4 Pt A","key":"934_CR199","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.bbadis.2018.01.023","volume":"1864","author":"LM Vargas","year":"2018","unstructured":"Vargas LM, Cerpa W, Mu\u00f1oz FJ, Zanlungo S, Alvarez AR. Amyloid-\u03b2 oligomers synaptotoxicity: the emerging role of EphA4\/c-Abl signaling in Alzheimer\u2019s Disease. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4 Pt A):1148\u201359.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"934_CR200","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","volume":"99","author":"A Ittner","year":"2018","unstructured":"Ittner A, Ittner LM. Dendritic Tau in Alzheimer\u2019s Disease. Neuron. 2018;99(1):13\u201327.","journal-title":"Neuron"},{"key":"934_CR201","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.biocel.2018.10.006","volume":"105","author":"N Saha","year":"2018","unstructured":"Saha N, Robev D, Mason EO, Himanen JP, Nikolov DB. Therapeutic potential of targeting the Eph\/ephrin signaling complex. Int J Biochem Cell Biol. 2018;105:123\u201333.","journal-title":"Int J Biochem Cell Biol"},{"key":"934_CR202","doi-asserted-by":"crossref","unstructured":"Niklison-Chirou MV, Agostini M, Amelio I, Melino G. Regulation of adult neurogenesis in mammalian brain. Int J Mol Sci. 2020;21(14).","DOI":"10.3390\/ijms21144869"},{"key":"934_CR203","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41232-020-00122-x","volume":"40","author":"Y Kase","year":"2020","unstructured":"Kase Y, Shimazaki T, Okano H. Current Understanding of adult neurogenesis in the mammalian brain: how does adult neurogenesis decrease with age? Inflamm Regen. 2020;40:10.","journal-title":"Inflamm Regen"},{"issue":"1","key":"934_CR204","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ajmg.b.32429","volume":"174","author":"E Horgusluoglu","year":"2017","unstructured":"Horgusluoglu E, Nudelman K, Nho K, Saykin AJ. Adult neurogenesis and neurodegenerative Diseases: A systems biology perspective. Am J Med Genet B Neuropsychiatr Genet. 2017;174(1):93\u2013112.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"6","key":"934_CR205","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1080\/00207454.2018.1545771","volume":"129","author":"J Fares","year":"2019","unstructured":"Fares J, Bou Diab Z, Nabha S, Fares Y. Neurogenesis in the adult hippocampus: history, regulation, and prospective roles. Int J Neurosci. 2019;129(6):598\u2013611.","journal-title":"Int J Neurosci"},{"key":"934_CR206","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neurobiolaging.2017.08.010","volume":"60","author":"E Horgusluoglu-Moloch","year":"2017","unstructured":"Horgusluoglu-Moloch E, Nho K, Risacher SL, Kim S, Foroud T, Shaw LM, et al. Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer\u2019s Disease. Neurobiol Aging. 2017;60:92\u2013103.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"934_CR207","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3233\/BPL-160034","volume":"3","author":"EM Jobe","year":"2017","unstructured":"Jobe EM, Zhao X. DNA methylation and adult neurogenesis. Brain Plast. 2017;3(1):5\u201326.","journal-title":"Brain Plast"},{"key":"934_CR208","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neubiorev.2014.01.005","volume":"40","author":"DM Smith","year":"2014","unstructured":"Smith DM, Bulkin DA. The form and function of hippocampal context representations. Neurosci Biobehav Rev. 2014;40:52\u201361.","journal-title":"Neurosci Biobehav Rev"},{"key":"934_CR209","doi-asserted-by":"crossref","unstructured":"Sung PS, Lin PY, Liu CH, Su HC, Tsai KJ. Neuroinflammation and neurogenesis in Alzheimer\u2019s Disease and potential therapeutic approaches. Int J Mol Sci. 2020;21(3).","DOI":"10.3390\/ijms21030701"},{"key":"934_CR210","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3389\/fcell.2020.00860","volume":"8","author":"SB Arredondo","year":"2020","unstructured":"Arredondo SB, Valenzuela-Bezanilla D, Mardones MD, Varela-Nallar L. Role of Wnt signaling in adult hippocampal neurogenesis in health and Disease. Front Cell Dev Biol. 2020;8:860.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"934_CR211","doi-asserted-by":"publisher","first-page":"108615","DOI":"10.1016\/j.celrep.2020.108615","volume":"34","author":"C Arber","year":"2021","unstructured":"Arber C, Lovejoy C, Harris L, Willumsen N, Alatza A, Casey JM, et al. Familial Alzheimer\u2019s Disease mutations in PSEN1 lead to premature human stem cell neurogenesis. Cell Rep. 2021;34(2):108615.","journal-title":"Cell Rep"},{"issue":"24","key":"934_CR212","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1093\/hmg\/ddu370","volume":"23","author":"P He","year":"2014","unstructured":"He P, Staufenbiel M, Li R, Shen Y. Deficiency of patched 1-induced Gli1 signal transduction results in astrogenesis in Swedish mutated APP Transgenic mice. Hum Mol Genet. 2014;23(24):6512\u201327.","journal-title":"Hum Mol Genet"},{"key":"934_CR213","doi-asserted-by":"publisher","first-page":"102271","DOI":"10.1016\/j.arr.2024.102271","volume":"96","author":"A Parashar","year":"2024","unstructured":"Parashar A, Jha D, Mehta V, Chauhan B, Ghosh P, Deb PK, et al. Sonic Hedgehog signalling pathway contributes in age-related disorders and Alzheimer\u2019s Disease. Ageing Res Rev. 2024;96:102271.","journal-title":"Ageing Res Rev"},{"key":"934_CR214","doi-asserted-by":"publisher","first-page":"711710","DOI":"10.3389\/fmolb.2021.711710","volume":"8","author":"C Yang","year":"2021","unstructured":"Yang C, Qi Y, Sun Z. The role of Sonic Hedgehog pathway in the development of the central nervous system and Aging-Related neurodegenerative Diseases. Front Mol Biosci. 2021;8:711710.","journal-title":"Front Mol Biosci"},{"key":"934_CR215","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fnagi.2020.00007","volume":"12","author":"Q Chen","year":"2020","unstructured":"Chen Q, Song H, Liu C, Xu J, Wei C, Wang W, et al. The interaction of EphA4 with PDGFR\u03b2 regulates proliferation and neuronal differentiation of neural progenitor cells in vitro and promotes neurogenesis in vivo. Front Aging Neurosci. 2020;12:7.","journal-title":"Front Aging Neurosci"},{"key":"934_CR216","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fnins.2016.00178","volume":"10","author":"C Hollands","year":"2016","unstructured":"Hollands C, Bartolotti N, Lazarov O. Alzheimer\u2019s Disease and hippocampal adult Neurogenesis; exploring shared mechanisms. Front Neurosci. 2016;10:178.","journal-title":"Front Neurosci"},{"issue":"1","key":"934_CR217","doi-asserted-by":"publisher","first-page":"9530","DOI":"10.1038\/s41598-017-10245-w","volume":"7","author":"A Mozzi","year":"2017","unstructured":"Mozzi A, Guerini FR, Forni D, Costa AS, Nemni R, Baglio F, et al. REST, a master regulator of neurogenesis, evolved under strong positive selection in humans and in Non human primates. Sci Rep. 2017;7(1):9530.","journal-title":"Sci Rep"},{"issue":"5","key":"934_CR218","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.celrep.2019.01.023","volume":"26","author":"K Meyer","year":"2019","unstructured":"Meyer K, Feldman HM, Lu T, Drake D, Lim ET, Ling KH, et al. REST and neural gene network dysregulation in iPSC models of Alzheimer\u2019s Disease. Cell Rep. 2019;26(5):1112\u2013e279.","journal-title":"Cell Rep"},{"issue":"7493","key":"934_CR219","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nature13163","volume":"507","author":"T Lu","year":"2014","unstructured":"Lu T, Aron L, Zullo J, Pan Y, Kim H, Chen Y, et al. REST and stress resistance in ageing and Alzheimer\u2019s Disease. Nature. 2014;507(7493):448\u201354.","journal-title":"Nature"},{"issue":"1","key":"934_CR220","doi-asserted-by":"publisher","first-page":"94","DOI":"10.14336\/AD.2018.0116","volume":"10","author":"P Huang","year":"2019","unstructured":"Huang P, Chen CS, Yang YH, Chou MC, Chang YH, Lai CL, et al. REST rs3796529 genotype and rate of functional deterioration in Alzheimer\u2019s Disease. Aging Dis. 2019;10(1):94\u2013101.","journal-title":"Aging Dis"},{"issue":"3","key":"934_CR221","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/ana.24349","volume":"77","author":"K Nho","year":"2015","unstructured":"Nho K, Kim S, Risacher SL, Shen L, Corneveaux JJ, Swaminathan S, et al. Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol. 2015;77(3):547\u201352.","journal-title":"Ann Neurol"},{"key":"934_CR222","doi-asserted-by":"crossref","unstructured":"Kim JP, Kim BH, Bice PJ, Seo SW, Bennett DA, Saykin AJ, et al. Integrative Co-methylation network analysis identifies novel DNA methylation signatures and their target genes in Alzheimer\u2019s Disease. Biol Psychiatry. 2022.","DOI":"10.1016\/j.biopsych.2022.06.020"},{"issue":"6","key":"934_CR223","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2217\/epi.15.39","volume":"7","author":"Q Du","year":"2015","unstructured":"Du Q, Luu PL, Stirzaker C, Clark SJ. Methyl-CpG-binding domain proteins: readers of the epigenome. Epigenomics. 2015;7(6):1051\u201373.","journal-title":"Epigenomics"},{"key":"934_CR224","doi-asserted-by":"crossref","unstructured":"Hsieh J, Zhao X. Genetics and epigenetics in adult neurogenesis. Cold Spring Harb Perspect Biol. 2016;8(6).","DOI":"10.1101\/cshperspect.a018911"},{"issue":"8","key":"934_CR225","doi-asserted-by":"publisher","first-page":"e70025","DOI":"10.1002\/cbf.70025","volume":"42","author":"S Suganya","year":"2024","unstructured":"Suganya S, Ashok BS, Ajith TA. A recent update on the role of Estrogen and progesterone in Alzheimer\u2019s Disease. Cell Biochem Funct. 2024;42(8):e70025.","journal-title":"Cell Biochem Funct"},{"issue":"4","key":"934_CR226","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/sj.jcbfm.9600573","volume":"28","author":"H Teng","year":"2008","unstructured":"Teng H, Zhang ZG, Wang L, Zhang RL, Zhang L, Morris D, et al. Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab. 2008;28(4):764\u201371.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"934_CR227","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.stemcr.2021.01.019","volume":"16","author":"KR Babcock","year":"2021","unstructured":"Babcock KR, Page JS, Fallon JR, Webb AE. Adult hippocampal neurogenesis in aging and Alzheimer\u2019s Disease. Stem Cell Rep. 2021;16(4):681\u201393.","journal-title":"Stem Cell Rep"},{"issue":"5","key":"934_CR228","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00401-016-1571-z","volume":"131","author":"RN Kalaria","year":"2016","unstructured":"Kalaria RN. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer\u2019s Disease. Acta Neuropathol. 2016;131(5):659\u201385.","journal-title":"Acta Neuropathol"},{"key":"934_CR229","doi-asserted-by":"crossref","unstructured":"Govindpani K, McNamara LG, Smith NR, Vinnakota C, Waldvogel HJ, Faull RL, et al. Vascular dysfunction in Alzheimer\u2019s Disease: a prelude to the pathological process or a consequence of it? J Clin Med. 2019;8(5).","DOI":"10.3390\/jcm8050651"},{"issue":"2","key":"934_CR230","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25(2):270\u20136.","journal-title":"Nat Med"},{"issue":"7806","key":"934_CR231","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71\u20136.","journal-title":"Nature"},{"issue":"1","key":"934_CR232","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40478-021-01199-2","volume":"9","author":"JS Reddy","year":"2021","unstructured":"Reddy JS, Allen M, Ho CCG, Oatman SR, \u0130\u015f \u00d6, Quicksall ZS, et al. Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer\u2019s Disease. Acta Neuropathol Commun. 2021;9(1):93.","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"934_CR233","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/s41588-024-01939-9","volume":"56","author":"LMP Shade","year":"2024","unstructured":"Shade LMP, Katsumata Y, Abner EL, Aung KZ, Claas SA, Qiao Q, et al. GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia. Nat Genet. 2024;56(11):2407\u201321.","journal-title":"Nat Genet"},{"issue":"6","key":"934_CR234","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00401-020-02215-w","volume":"140","author":"N Korte","year":"2020","unstructured":"Korte N, Nortley R, Attwell D. Cerebral blood flow decrease as an early pathological mechanism in Alzheimer\u2019s Disease. Acta Neuropathol. 2020;140(6):793\u2013810.","journal-title":"Acta Neuropathol"},{"key":"934_CR235","doi-asserted-by":"crossref","unstructured":"Karanth S, Nelson PT, Katsumata Y, Kryscio RJ, Schmitt FA, Fardo DW, et al. Prevalence and clinical phenotype of quadruple misfolded proteins in older adults. JAMA Neurol. 2020.","DOI":"10.1001\/jamaneurol.2020.1741"},{"issue":"1","key":"934_CR236","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","volume":"14","author":"D Twohig","year":"2019","unstructured":"Twohig D, Nielsen HM. \u03b1-synuclein in the pathophysiology of Alzheimer\u2019s Disease. Mol Neurodegener. 2019;14(1):23.","journal-title":"Mol Neurodegener"},{"key":"934_CR237","doi-asserted-by":"crossref","unstructured":"Condello C, Westaway D, Prusiner SB. Expanding the prion paradigm to include Alzheimer and Parkinson Diseases. JAMA Neurol. 2024.","DOI":"10.1001\/jamaneurol.2024.2464"},{"issue":"1","key":"934_CR238","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40035-024-00407-y","volume":"13","author":"W Li","year":"2024","unstructured":"Li W, Li JY. Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration. Transl Neurodegener. 2024;13(1):16.","journal-title":"Transl Neurodegener"},{"issue":"3","key":"934_CR239","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3233\/JPD-201965","volume":"10","author":"R Kayed","year":"2020","unstructured":"Kayed R, Dettmer U, Lesn\u00e9 SE. Soluble endogenous oligomeric \u03b1-synuclein species in neurodegenerative Diseases: Expression, spreading, and cross-talk. J Parkinsons Dis. 2020;10(3):791\u2013818.","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"934_CR240","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/14737159.2022.2068952","volume":"22","author":"MF Beatino","year":"2022","unstructured":"Beatino MF, De Luca C, Campese N, Belli E, Piccarducci R, Giampietri L, et al. \u03b1-synuclein as an emerging pathophysiological biomarker of Alzheimer\u2019s Disease. Expert Rev Mol Diagn. 2022;22(4):411\u201325.","journal-title":"Expert Rev Mol Diagn"},{"issue":"12","key":"934_CR241","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","volume":"91","author":"DW Dickson","year":"2018","unstructured":"Dickson DW, Heckman MG, Murray ME, Soto AI, Walton RL, Diehl NN, et al. APOE \u03b54 is associated with severity of lewy body pathology independent of Alzheimer pathology. Neurology. 2018;91(12):e1182\u201395.","journal-title":"Neurology"},{"issue":"1","key":"934_CR242","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s40478-020-01050-0","volume":"8","author":"SL Strickland","year":"2020","unstructured":"Strickland SL, Morel H, Prusinski C, Allen M, Patel TA, Carrasquillo MM, et al. Association of ABI3 and PLCG2 missense variants with Disease risk and neuropathology in lewy body Disease and progressive supranuclear palsy. Acta Neuropathol Commun. 2020;8(1):172.","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"934_CR243","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1002\/alz.13858","volume":"20","author":"D Tosun","year":"2024","unstructured":"Tosun D, Hausle Z, Iwaki H, Thropp P, Lamoureux J, Lee EB, et al. A cross-sectional study of \u03b1-synuclein seed amplification assay in Alzheimer\u2019s Disease neuroimaging initiative: prevalence and associations with Alzheimer\u2019s Disease biomarkers and cognitive function. Alzheimers Dement. 2024;20(8):5114\u201331.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"934_CR244","doi-asserted-by":"publisher","first-page":"8444","DOI":"10.1002\/alz.14276","volume":"20","author":"D Tosun","year":"2024","unstructured":"Tosun D, Hausle Z, Thropp P, Concha-Marambio L, Lamoureux J, Lebovitz R, et al. Association of CSF \u03b1-synuclein seed amplification assay positivity with Disease progression and cognitive decline: A longitudinal Alzheimer\u2019s Disease neuroimaging initiative study. Alzheimers Dement. 2024;20(12):8444\u201360.","journal-title":"Alzheimers Dement"},{"key":"934_CR245","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fnmol.2020.00026","volume":"13","author":"W Huang","year":"2020","unstructured":"Huang W, Zhou Y, Tu L, Ba Z, Huang J, Huang N, et al. TDP-43: from Alzheimer\u2019s Disease to Limbic-Predominant Age-Related TDP-43 encephalopathy. Front Mol Neurosci. 2020;13:26.","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"934_CR246","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/14728222.2018.1439923","volume":"22","author":"E Buratti","year":"2018","unstructured":"Buratti E. TDP-43 post-translational modifications in health and Disease. Expert Opin Ther Targets. 2018;22(3):279\u201393.","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"934_CR247","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","volume":"16","author":"A Meneses","year":"2021","unstructured":"Meneses A, Koga S, O\u2019Leary J, Dickson DW, Bu G, Zhao N. TDP-43 pathology in Alzheimer\u2019s Disease. Mol Neurodegener. 2021;16(1):84.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"934_CR248","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs KA, Murray ME, Whitwell JL, Parisi JE, Petrucelli L, Jack CR, et al. Staging TDP-43 pathology in Alzheimer\u2019s Disease. Acta Neuropathol. 2014;127(3):441\u201350.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"934_CR249","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s Disease. Mol Neurodegener. 2019;14(1):32.","journal-title":"Mol Neurodegener"},{"key":"934_CR250","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fnagi.2020.00166","volume":"12","author":"N Zhang","year":"2020","unstructured":"Zhang N, Gu D, Meng M, Gordon ML. TDP-43 is elevated in plasma Neuronal-Derived exosomes of patients with Alzheimer\u2019s Disease. Front Aging Neurosci. 2020;12:166.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"934_CR251","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3233\/JAD-161116","volume":"58","author":"SM Williams","year":"2017","unstructured":"Williams SM, Schulz P, Rosenberry TL, Caselli RJ, Sierks MR. Blood-Based oligomeric and other protein variant biomarkers to facilitate Pre-Symptomatic diagnosis and staging of Alzheimer\u2019s Disease. J Alzheimers Dis. 2017;58(1):23\u201335.","journal-title":"J Alzheimers Dis"},{"key":"934_CR252","doi-asserted-by":"crossref","unstructured":"S\u0119dzikowska A, Szablewski L. Insulin and insulin resistance in Alzheimer\u2019s Disease. Int J Mol Sci. 2021;22(18).","DOI":"10.3390\/ijms22189987"},{"key":"934_CR253","doi-asserted-by":"crossref","unstructured":"Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Giau VV. Type 3 diabetes and its role implications in Alzheimer\u2019s Disease. Int J Mol Sci. 2020;21(9).","DOI":"10.3390\/ijms21093165"},{"key":"934_CR254","doi-asserted-by":"publisher","first-page":"104707","DOI":"10.1016\/j.neuint.2020.104707","volume":"135","author":"A Akhtar","year":"2020","unstructured":"Akhtar A, Sah SP. Insulin signaling pathway and related molecules: role in neurodegeneration and Alzheimer\u2019s Disease. Neurochem Int. 2020;135:104707.","journal-title":"Neurochem Int"},{"issue":"1","key":"934_CR255","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/path.2912","volume":"225","author":"Y Liu","year":"2011","unstructured":"Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Deficient brain insulin signalling pathway in Alzheimer\u2019s Disease and diabetes. J Pathol. 2011;225(1):54\u201362.","journal-title":"J Pathol"},{"issue":"9","key":"934_CR256","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar D, Craft S. Brain insulin resistance in Alzheimer\u2019s Disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 2020;19(9):758\u201366.","journal-title":"Lancet Neurol"},{"issue":"7","key":"934_CR257","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.2337\/db14-0568","volume":"63","author":"A Kleinridders","year":"2014","unstructured":"Kleinridders A, Ferris HA, Cai W, Kahn CR. Insulin action in brain regulates systemic metabolism and brain function. Diabetes. 2014;63(7):2232\u201343.","journal-title":"Diabetes"},{"issue":"28","key":"934_CR258","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","volume":"29","author":"QL Ma","year":"2009","unstructured":"Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech W, Gant DJ, et al. Beta-amyloid oligomers induce phosphorylation of Tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and Curcumin. J Neurosci. 2009;29(28):9078\u201389.","journal-title":"J Neurosci"},{"issue":"4","key":"934_CR259","doi-asserted-by":"publisher","first-page":"112335","DOI":"10.1016\/j.celrep.2023.112335","volume":"42","author":"H Li","year":"2023","unstructured":"Li H, Guglielmetti C, Sei YJ, Zilberter M, Le Page LM, Shields L, et al. Neurons require glucose uptake and Glycolysis in vivo. Cell Rep. 2023;42(4):112335.","journal-title":"Cell Rep"},{"key":"934_CR260","doi-asserted-by":"crossref","unstructured":"Szablewski L. Brain Glucose Transporters: role in pathogenesis and potential targets for the treatment of Alzheimer\u2019s Disease. Int J Mol Sci. 2021;22(15).","DOI":"10.3390\/ijms22158142"},{"issue":"1","key":"934_CR261","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12974-023-02914-7","volume":"20","author":"M Corraliza-Gomez","year":"2023","unstructured":"Corraliza-Gomez M, Bermejo T, Lilue J, Rodriguez-Iglesias N, Valero J, Cozar-Castellano I, et al. Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer\u2019s Disease and brain aging. J Neuroinflammation. 2023;20(1):233.","journal-title":"J Neuroinflammation"},{"issue":"7","key":"934_CR262","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1007\/s13346-024-01558-1","volume":"14","author":"CYJ Wong","year":"2024","unstructured":"Wong CYJ, Baldelli A, Hoyos CM, Tietz O, Ong HX, Traini D. Insulin delivery to the brain via the nasal route: unraveling the potential for Alzheimer\u2019s Disease therapy. Drug Deliv Transl Res. 2024;14(7):1776\u201393.","journal-title":"Drug Deliv Transl Res"},{"key":"934_CR263","doi-asserted-by":"publisher","first-page":"106550","DOI":"10.1016\/j.phrs.2022.106550","volume":"186","author":"KO Kopp","year":"2022","unstructured":"Kopp KO, Glotfelty EJ, Li Y, Greig NH. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative Disease treatment. Pharmacol Res. 2022;186:106550.","journal-title":"Pharmacol Res"},{"key":"934_CR264","doi-asserted-by":"publisher","first-page":"1033479","DOI":"10.3389\/fendo.2022.1033479","volume":"13","author":"H Du","year":"2022","unstructured":"Du H, Meng X, Yao Y, Xu J. The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer\u2019s Disease. Front Endocrinol (Lausanne). 2022;13:1033479.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"934_CR265","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2147\/DDDT.S409373","volume":"17","author":"S Dutta","year":"2023","unstructured":"Dutta S, Shah RB, Singhal S, Dutta SB, Bansal S, Sinha S, et al. Metformin: A review of potential mechanism and therapeutic utility beyond diabetes. Drug Des Devel Ther. 2023;17:1907\u201332.","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"934_CR266","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.7150\/thno.71360","volume":"12","author":"S Chen","year":"2022","unstructured":"Chen S, Gan D, Lin S, Zhong Y, Chen M, Zou X, et al. Metformin in aging and aging-related Diseases: clinical applications and relevant mechanisms. Theranostics. 2022;12(6):2722\u201340.","journal-title":"Theranostics"},{"key":"934_CR267","doi-asserted-by":"crossref","unstructured":"Wagner N, Wagner KD. The role of PPARs in Disease. Cells. 2020;9(11).","DOI":"10.3390\/cells9112367"},{"key":"934_CR268","first-page":"174550651881799","volume":"14","author":"MK Andrew","year":"2018","unstructured":"Andrew MK, Tierney MC. The puzzle of sex, gender and Alzheimer\u2019s Disease: why are women more often affected than men? Women\u2019s Health. 2018;14:1745506518817995.","journal-title":"Women\u2019s Health"},{"issue":"19","key":"934_CR269","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1042\/CS20160004","volume":"130","author":"R Ostan","year":"2016","unstructured":"Ostan R, Monti D, Gueresi P, Bussolotto M, Franceschi C, Baggio G. Gender, aging and longevity in humans: an update of an intriguing\/neglected scenario paving the way to a gender-specific medicine. Clin Sci (Lond). 2016;130(19):1711\u201325.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"934_CR270","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ncl.2023.01.001","volume":"41","author":"NT Aggarwal","year":"2023","unstructured":"Aggarwal NT, Mielke MM. Sex differences in Alzheimer\u2019s Disease. Neurol Clin. 2023;41(2):343\u201358.","journal-title":"Neurol Clin"},{"issue":"s1","key":"934_CR271","doi-asserted-by":"publisher","first-page":"S235","DOI":"10.3233\/JAD-240899","volume":"101","author":"J Sayfullaeva","year":"2024","unstructured":"Sayfullaeva J, McLoughlin J, Kwakowsky A. Hormone replacement therapy and Alzheimer\u2019s Disease: current state of knowledge and implications for clinical use. J Alzheimers Dis. 2024;101(s1):S235\u201361.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"934_CR272","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1212\/WNL.0000000000000033","volume":"82","author":"R Bove","year":"2014","unstructured":"Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA, et al. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 2014;82(3):222\u20139.","journal-title":"Neurology"},{"issue":"1","key":"934_CR273","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13195-022-01121-5","volume":"15","author":"RNM Saleh","year":"2023","unstructured":"Saleh RNM, Hornberger M, Ritchie CW, Minihane AM. Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European prevention of Alzheimer\u2019s Disease (EPAD) cohort. Alzheimers Res Ther. 2023;15(1):10.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"934_CR274","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.yhbeh.2012.06.003","volume":"63","author":"M Singh","year":"2013","unstructured":"Singh M, Su C. Progesterone and neuroprotection. Horm Behav. 2013;63(2):284\u201390.","journal-title":"Horm Behav"},{"key":"934_CR275","doi-asserted-by":"publisher","first-page":"1286066","DOI":"10.3389\/fendo.2024.1286066","volume":"15","author":"M Singh","year":"2024","unstructured":"Singh M, Krishnamoorthy VR, Kim S, Khurana S, LaPorte HM. Brain-derived neuerotrophic factor and related mechanisms that mediate and influence progesterone-induced neuroprotection. Front Endocrinol (Lausanne). 2024;15:1286066.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"934_CR276","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5534\/wjmh.210175","volume":"40","author":"VE Bianchi","year":"2022","unstructured":"Bianchi VE. Impact of testosterone on Alzheimer\u2019s Disease. World J Mens Health. 2022;40(2):243\u201356.","journal-title":"World J Mens Health"},{"issue":"1","key":"934_CR277","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1111\/ejn.16360","volume":"60","author":"M Rishabh, Rohilla","year":"2024","unstructured":"Rishabh, Rohilla M, Bansal S, Bansal N, Chauhan S, Sharma S, et al. Estrogen signalling and Alzheimer\u2019s Disease: decoding molecular mechanisms for therapeutic breakthrough. Eur J Neurosci. 2024;60(1):3466\u201390.","journal-title":"Eur J Neurosci"},{"issue":"4","key":"934_CR278","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.24135","volume":"75","author":"A Altmann","year":"2014","unstructured":"Altmann A, Tian L, Henderson VW, Greicius MD. Sex modifies the APOE-related risk of developing Alzheimer Disease. Ann Neurol. 2014;75(4):563\u201373.","journal-title":"Ann Neurol"},{"issue":"29","key":"934_CR279","doi-asserted-by":"publisher","first-page":"26663","DOI":"10.18632\/oncotarget.5185","volume":"6","author":"F Sampedro","year":"2015","unstructured":"Sampedro F, Vilaplana E, de Leon MJ, Alcolea D, Pegueroles J, Montal V, et al. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls. Oncotarget. 2015;6(29):26663\u201374.","journal-title":"Oncotarget"},{"key":"934_CR280","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.coisb.2017.04.015","volume":"3","author":"M Caldera","year":"2017","unstructured":"Caldera M, Buphamalai P, M\u00fcller F, Menche J. Interactome-based approaches to human Disease. Curr Opin Syst Biology. 2017;3:88\u201394.","journal-title":"Curr Opin Syst Biology"},{"issue":"11","key":"934_CR281","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.neuron.2022.03.008","volume":"110","author":"JS Sadick","year":"2022","unstructured":"Sadick JS, O\u2019Dea MR, Hasel P, Dykstra T, Faustin A, Liddelow SA. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer\u2019s Disease. Neuron. 2022;110(11):1788\u2013e80510.","journal-title":"Neuron"},{"issue":"1","key":"934_CR282","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s13311-021-01152-0","volume":"19","author":"MI Kamboh","year":"2022","unstructured":"Kamboh MI. Genomics and functional genomics of Alzheimer\u2019s Disease. Neurotherapeutics. 2022;19(1):152\u201372.","journal-title":"Neurotherapeutics"},{"key":"934_CR283","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clinbiochem.2018.06.011","volume":"59","author":"GM Sancesario","year":"2018","unstructured":"Sancesario GM, Bernardini S. Alzheimer\u2019s Disease in the omics era. Clin Biochem. 2018;59:9\u201316.","journal-title":"Clin Biochem"},{"key":"934_CR284","unstructured":"Project AsDS. List of AD Loci and genes with genetic evidence compiled by ADSP gene verification committee 2023 [updated August 17th, 2023; cited 2025 July 27. 2025]. Available from: https:\/\/adsp.niagads.org\/gvc-top-hits-list\/."},{"issue":"7409","key":"934_CR285","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, et al. A mutation in APP protects against Alzheimer\u2019s Disease and age-related cognitive decline. Nature. 2012;488(7409):96\u20139.","journal-title":"Nature"},{"key":"934_CR286","doi-asserted-by":"crossref","unstructured":"Frisoni GB, Altomare D, Thal DR, van der Ribaldi F, Ossenkoppele R, et al. The probabilistic model of Alzheimer Disease: the amyloid hypothesis revised. Nat Rev Neurosci. 2021.","DOI":"10.1038\/s41583-021-00533-w"},{"issue":"3","key":"934_CR287","doi-asserted-by":"publisher","first-page":"e1002270","DOI":"10.1371\/journal.pmed.1002270","volume":"14","author":"HM Lanoiselee","year":"2017","unstructured":"Lanoiselee HM, Nicolas G, Wallon D, Rovelet-Lecrux A, Lacour M, Rousseau S, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer Disease: A genetic screening study of Familial and sporadic cases. PLoS Med. 2017;14(3):e1002270.","journal-title":"PLoS Med"},{"key":"934_CR288","doi-asserted-by":"crossref","unstructured":"Rabinovici GD, Dubal DB. Rare APOE missense variants-can we overcome APOE \u03b54 and Alzheimer Disease risk? JAMA Neurol. 2022.","DOI":"10.1001\/jamaneurol.2022.0854"},{"issue":"3","key":"934_CR289","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ncl.2007.03.009","volume":"25","author":"N Ertekin-Taner","year":"2007","unstructured":"Ertekin-Taner N. Genetics of Alzheimer\u2019s Disease: a centennial review. Neurol Clin. 2007;25(3):611\u201367. v.","journal-title":"Neurol Clin"},{"issue":"1","key":"934_CR290","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","volume":"15","author":"Z Li","year":"2020","unstructured":"Li Z, Shue F, Zhao N, Shinohara M, Bu G. APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s Disease. Mol Neurodegener. 2020;15(1):63.","journal-title":"Mol Neurodegener"},{"issue":"11","key":"934_CR291","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez JF, Lopera F, O\u2019Hare M, Delgado-Tirado S, Marino C, Chmielewska N, et al. Resistance to autosomal dominant Alzheimer\u2019s Disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25(11):1680\u20133.","journal-title":"Nat Med"},{"issue":"613","key":"934_CR292","doi-asserted-by":"publisher","first-page":"eabc9375","DOI":"10.1126\/scitranslmed.abc9375","volume":"13","author":"CC Liu","year":"2021","unstructured":"Liu CC, Murray ME, Li X, Zhao N, Wang N, Heckman MG, et al. APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. Sci Transl Med. 2021;13(613):eabc9375.","journal-title":"Sci Transl Med"},{"key":"934_CR293","doi-asserted-by":"crossref","unstructured":"Lanfranco MF, Ng CA, Rebeck GW. ApoE lipidation as a therapeutic target in Alzheimer\u2019s Disease. Int J Mol Sci. 2020;21(17).","DOI":"10.3390\/ijms21176336"},{"issue":"7","key":"934_CR294","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jamaneurol.2022.1166","volume":"79","author":"Y Le Guen","year":"2022","unstructured":"Le Guen Y, Belloy ME, Grenier-Boley B, de Rojas I, Castillo-Morales A, Jansen I, et al. Association of rare APOE missense variants V236E and R251G with risk of Alzheimer Disease. JAMA Neurol. 2022;79(7):652\u201363.","journal-title":"JAMA Neurol"},{"issue":"5","key":"934_CR295","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/s41591-023-02318-3","volume":"29","author":"F Lopera","year":"2023","unstructured":"Lopera F, Marino C, Chandrahas AS, O\u2019Hare M, Villalba-Moreno ND, Aguillon D, et al. Resilience to autosomal dominant Alzheimer\u2019s Disease in a Reelin-COLBOS heterozygous man. Nat Med. 2023;29(5):1243\u201352.","journal-title":"Nat Med"},{"issue":"12","key":"934_CR296","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s Disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"934_CR297","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-022-00588-y","volume":"17","author":"J Hou","year":"2022","unstructured":"Hou J, Chen Y, Grajales-Reyes G, Colonna M. TREM2 dependent and independent functions of microglia in Alzheimer\u2019s Disease. Mol Neurodegener. 2022;17(1):84.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"934_CR298","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","volume":"13","author":"M Gratuze","year":"2018","unstructured":"Gratuze M, Leyns CEG, Holtzman DM. New insights into the role of TREM2 in Alzheimer\u2019s Disease. Mol Neurodegener. 2018;13(1):66.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"934_CR299","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-122311","volume":"35","author":"C Pottier","year":"2013","unstructured":"Pottier C, Wallon D, Rousseau S, Rovelet-Lecrux A, Richard AC, Rollin-Sillaire A, et al. TREM2 R47H variant as a risk factor for early-onset Alzheimer\u2019s Disease. J Alzheimers Dis. 2013;35(1):45\u20139.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"934_CR300","doi-asserted-by":"publisher","first-page":"e4441","DOI":"10.1016\/j.neurobiolaging.2013.08.011","volume":"35","author":"A Ruiz","year":"2014","unstructured":"Ruiz A, Dols-Icardo O, Bullido MJ, Pastor P, Rodr\u00edguez-Rodr\u00edguez E, L\u00f3pez de Munain A, et al. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer\u2019s Disease and frontotemporal dementia. Neurobiol Aging. 2014;35(2):e4441\u20134.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"934_CR301","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41398-018-0150-6","volume":"8","author":"RE Marioni","year":"2018","unstructured":"Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, Hill WD, et al. GWAS on family history of Alzheimer\u2019s Disease. Transl Psychiatry. 2018;8(1):99.","journal-title":"Transl Psychiatry"},{"issue":"3","key":"934_CR302","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s Disease risk. Nat Genet. 2019;51(3):404\u201313.","journal-title":"Nat Genet"},{"issue":"3","key":"934_CR303","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s Disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330.","journal-title":"Nat Genet"},{"issue":"1","key":"934_CR304","doi-asserted-by":"publisher","first-page":"8251","DOI":"10.1038\/s41467-024-52298-2","volume":"15","author":"K Nho","year":"2024","unstructured":"Nho K, Risacher SL, Apostolova LG, Bice PJ, Brosch JR, Deardorff R, et al. CYP1B1-RMDN2 Alzheimer\u2019s Disease endophenotype locus identified for cerebral Tau PET. Nat Commun. 2024;15(1):8251.","journal-title":"Nat Commun"},{"key":"934_CR305","doi-asserted-by":"publisher","first-page":"101346","DOI":"10.1016\/j.arr.2021.101346","volume":"69","author":"H Hampel","year":"2021","unstructured":"Hampel H, Nistic\u00f2 R, Seyfried NT, Levey AI, Modeste E, Lemercier P, et al. Omics sciences for systems biology in Alzheimer\u2019s Disease: State-of-the-art of the evidence. Ageing Res Rev. 2021;69:101346.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"934_CR306","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s12035-016-0357-6","volume":"55","author":"TJ Qazi","year":"2018","unstructured":"Qazi TJ, Quan Z, Mir A, Qing H. Epigenetics in Alzheimer\u2019s Disease: perspective of DNA methylation. Mol Neurobiol. 2018;55(2):1026\u201344.","journal-title":"Mol Neurobiol"},{"key":"934_CR307","doi-asserted-by":"crossref","unstructured":"Maity S, Farrell K, Navabpour S, Narayanan SN, Jarome TJ. Epigenetic mechanisms in memory and cognitive decline associated with aging and Alzheimer\u2019s Disease. Int J Mol Sci. 2021;22(22).","DOI":"10.3390\/ijms222212280"},{"key":"934_CR308","doi-asserted-by":"crossref","unstructured":"Younesian S, Yousefi AM, Momeny M, Ghaffari SH, Bashash D. The DNA methylation in neurological Diseases. Cells. 2022;11(21).","DOI":"10.3390\/cells11213439"},{"key":"934_CR309","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Ortiz S, Pinto-Fraga J, Valenzuela PL, Mart\u00edn-Hern\u00e1ndez J, Seisdedos MM, Garc\u00eda-L\u00f3pez O, et al. Physical exercise and Alzheimer\u2019s Disease: effects on pathophysiological molecular pathways of the Disease. Int J Mol Sci. 2021;22(6).","DOI":"10.3390\/ijms22062897"},{"key":"934_CR310","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mrrev.2017.10.001","volume":"780","author":"M Christmann","year":"2019","unstructured":"Christmann M, Kaina B. Epigenetic regulation of DNA repair genes and implications for tumor therapy. Mutat Res Rev Mutat Res. 2019;780:15\u201328.","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"5","key":"934_CR311","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7150\/ijbs.11218","volume":"11","author":"H Meng","year":"2015","unstructured":"Meng H, Cao Y, Qin J, Song X, Zhang Q, Shi Y, et al. DNA methylation, its mediators and genome integrity. Int J Biol Sci. 2015;11(5):604\u201317.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"934_CR312","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13148-020-00864-y","volume":"12","author":"A Vasanthakumar","year":"2020","unstructured":"Vasanthakumar A, Davis JW, Idler K, Waring JF, Asque E, Riley-Gillis B, et al. Harnessing peripheral DNA methylation differences in the Alzheimer\u2019s Disease neuroimaging initiative (ADNI) to reveal novel biomarkers of Disease. Clin Epigenetics. 2020;12(1):84.","journal-title":"Clin Epigenetics"},{"key":"934_CR313","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1326-6-31","volume":"6","author":"N Ertekin-Taner","year":"2011","unstructured":"Ertekin-Taner N. Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer\u2019s Disease. Mol Neurodegener. 2011;6:31.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"934_CR314","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1212\/WNL.0b013e3182605801","volume":"79","author":"M Allen","year":"2012","unstructured":"Allen M, Zou F, Chai HS, Younkin CS, Crook J, Pankratz VS, et al. Novel late-onset Alzheimer Disease loci variants associate with brain gene expression. Neurology. 2012;79(3):221\u20138.","journal-title":"Neurology"},{"issue":"6","key":"934_CR315","doi-asserted-by":"publisher","first-page":"e1002707","DOI":"10.1371\/journal.pgen.1002707","volume":"8","author":"F Zou","year":"2012","unstructured":"Zou F, Chai HS, Younkin CS, Allen M, Crook J, Pankratz VS, et al. Brain expression genome-wide association study (eGWAS) identifies human Disease-associated variants. PLoS Genet. 2012;8(6):e1002707.","journal-title":"PLoS Genet"},{"issue":"2","key":"934_CR316","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1212\/NXG.0000000000000012","volume":"1","author":"M Allen","year":"2015","unstructured":"Allen M, Kachadoorian M, Carrasquillo MM, Karhade A, Manly L, Burgess JD, et al. Late-onset Alzheimer Disease risk variants mark brain regulatory loci. Neurol Genet. 2015;1(2):e15.","journal-title":"Neurol Genet"},{"issue":"1","key":"934_CR317","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1038\/s41598-018-22701-2","volume":"8","author":"A Annese","year":"2018","unstructured":"Annese A, Manzari C, Lionetti C, Picardi E, Horner DS, Chiara M, et al. Whole transcriptome profiling of Late-Onset Alzheimer\u2019s Disease patients provides insights into the molecular changes involved in the Disease. Sci Rep. 2018;8(1):4282.","journal-title":"Sci Rep"},{"key":"934_CR318","doi-asserted-by":"publisher","first-page":"101664","DOI":"10.1016\/j.pneurobio.2019.101664","volume":"182","author":"CA Ju\u017awik","year":"2019","unstructured":"Ju\u017awik CA, Zhang SSD, Paradis-Isler Y, Sylvester N, Amar-Zifkin A. MicroRNA dysregulation in neurodegenerative Diseases: A systematic review. Prog Neurobiol. 2019;182:101664.","journal-title":"Prog Neurobiol"},{"issue":"10","key":"934_CR319","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1002\/acn3.52175","volume":"11","author":"SW Han","year":"2024","unstructured":"Han SW, Park YH, Bice PJ, Bennett DA, Kim S, Saykin AJ, et al. miR-133b as a potential regulator of a synaptic NPTX2 protein in Alzheimer\u2019s Disease. Ann Clin Transl Neurol. 2024;11(10):2799\u2013804.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"934_CR320","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13195-023-01366-8","volume":"16","author":"SW Han","year":"2024","unstructured":"Han SW, Pyun JM, Bice PJ, Bennett DA, Saykin AJ, Kim SY, et al. miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer\u2019s Disease. Alzheimers Res Ther. 2024;16(1):5.","journal-title":"Alzheimers Res Ther"},{"issue":"37","key":"934_CR321","doi-asserted-by":"publisher","first-page":"32416","DOI":"10.1074\/jbc.M111.258970","volume":"286","author":"S Koyanagi","year":"2011","unstructured":"Koyanagi S, Hamdan AM, Horiguchi M, Kusunose N, Okamoto A, Matsunaga N, et al. cAMP-response element (CRE)-mediated transcription by activating transcription factor-4 (ATF4) is essential for circadian expression of the Period2 gene. J Biol Chem. 2011;286(37):32416\u201323.","journal-title":"J Biol Chem"},{"issue":"5","key":"934_CR322","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.3892\/mmr.2016.5005","volume":"13","author":"K Yan","year":"2016","unstructured":"Yan K, Gao LN, Cui YL, Zhang Y, Zhou X. The Cyclic AMP signaling pathway: exploring targets for successful drug discovery (Review). Mol Med Rep. 2016;13(5):3715\u201323.","journal-title":"Mol Med Rep"},{"issue":"6","key":"934_CR323","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.bbamcr.2016.12.023","volume":"1864","author":"Q Liu","year":"2017","unstructured":"Liu Q. TMBIM-mediated Ca(2+) homeostasis and cell death. Biochim Biophys Acta Mol Cell Res. 2017;1864(6):850\u20137.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"9","key":"934_CR324","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1111\/febs.15179","volume":"287","author":"C Lebeaupin","year":"2020","unstructured":"Lebeaupin C, Blanc M, Vallee D, Keller H, Bailly-Maitre B. BAX inhibitor-1: between stress and survival. FEBS J. 2020;287(9):1722\u201336.","journal-title":"FEBS J"},{"issue":"9","key":"934_CR325","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/alz.12092","volume":"16","author":"K Nho","year":"2020","unstructured":"Nho K, Nudelman K, Allen M, Hodges A, Kim S, Risacher SL, et al. Genome-wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer\u2019s pathology. Alzheimers Dement. 2020;16(9):1213\u201323.","journal-title":"Alzheimers Dement"},{"key":"934_CR326","doi-asserted-by":"crossref","unstructured":"Nasheuer HP, Meaney AM, Hulshoff T, Thiele I, Onwubiko NO. Replication protein A, the main eukaryotic single-stranded DNA binding protein, a focal point in cellular DNA metabolism. Int J Mol Sci. 2024;25(1).","DOI":"10.3390\/ijms25010588"},{"issue":"2","key":"934_CR327","doi-asserted-by":"publisher","first-page":"eabb5398","DOI":"10.1126\/sciadv.abb5398","volume":"7","author":"RA Neff","year":"2021","unstructured":"Neff RA, Wang M, Vatansever S, Guo L, Ming C, Wang Q, et al. Molecular subtyping of Alzheimer\u2019s Disease using RNA sequencing data reveals novel mechanisms and targets. Sci Adv. 2021;7(2):eabb5398.","journal-title":"Sci Adv"},{"issue":"2","key":"934_CR328","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1074\/mcp.R115.053330","volume":"15","author":"G Moya-Alvarado","year":"2016","unstructured":"Moya-Alvarado G, Gershoni-Emek N, Perlson E, Bronfman FC. Neurodegeneration and Alzheimer\u2019s Disease (AD). What can proteomics tell Us about the Alzheimer\u2019s brain? Mol Cell Proteom. 2016;15(2):409\u201325.","journal-title":"Mol Cell Proteom"},{"issue":"1","key":"934_CR329","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-021-00474-z","volume":"16","author":"B Bai","year":"2021","unstructured":"Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H, et al. Proteomic landscape of Alzheimer\u2019s Disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener. 2021;16(1):55.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"934_CR330","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4331\/wjbc.v12.i5.57","volume":"12","author":"S Al-Amrani","year":"2021","unstructured":"Al-Amrani S, Al-Jabri Z, Al-Zaabi A, Alshekaili J, Al-Khabori M. Proteomics: concepts and applications in human medicine. World J Biol Chem. 2021;12(5):57\u201369.","journal-title":"World J Biol Chem"},{"issue":"4","key":"934_CR331","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.neuron.2020.04.031","volume":"106","author":"B Bai","year":"2020","unstructured":"Bai B, Wang X, Li Y, Chen PC, Yu K, Dey KK, et al. Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s Disease progression. Neuron. 2020;106(4):700.","journal-title":"Neuron"},{"issue":"1","key":"934_CR332","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","volume":"7","author":"CD Whelan","year":"2019","unstructured":"Whelan CD, Mattsson N, Nagle MW, Vijayaraghavan S, Hyde C, Janelidze S, et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer\u2019s Disease. Acta Neuropathol Commun. 2019;7(1):169.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"934_CR333","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jalz.2018.10.006","volume":"15","author":"F Xiong","year":"2019","unstructured":"Xiong F, Ge W, Ma C. Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer\u2019s Disease. Alzheimers Dement. 2019;15(3):429\u201340.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"934_CR334","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","volume":"13","author":"JB Toledo","year":"2017","unstructured":"Toledo JB, Arnold M, Kastenmuller G, Chang R, Baillie RA, Han X, et al. Metabolic network failures in Alzheimer\u2019s Disease: A biochemical road map. Alzheimers Dement. 2017;13(9):965\u201384.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"934_CR335","doi-asserted-by":"publisher","first-page":"a000588","DOI":"10.1101\/mcs.a000588","volume":"1","author":"CB Clish","year":"2015","unstructured":"Clish CB. Metabolomics: an emerging but powerful tool for precision medicine. Cold Spring Harb Mol Case Stud. 2015;1(1):a000588.","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"934_CR336","doi-asserted-by":"crossref","unstructured":"Horgusluoglu E, Neff R, Song WM, Wang M, Wang Q, Arnold M, et al. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer\u2019s Disease. Alzheimers Dement. 2021.","DOI":"10.1002\/alz.12468"},{"issue":"1","key":"934_CR337","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s13311-017-0598-8","volume":"15","author":"LM Cox","year":"2018","unstructured":"Cox LM, Weiner HL. Microbiota signaling pathways that influence neurologic Disease. Neurotherapeutics. 2018;15(1):135\u201345.","journal-title":"Neurotherapeutics"},{"key":"934_CR338","doi-asserted-by":"crossref","unstructured":"Tilocca B, Pieroni L, Soggiu A, Britti D, Bonizzi L, Roncada P, et al. Gut-brain axis and neurodegeneration: state-of-the-art of meta-omics sciences for microbiota characterization. Int J Mol Sci. 2020;21(11).","DOI":"10.3390\/ijms21114045"},{"issue":"1","key":"934_CR339","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1038\/s41598-022-07632-3","volume":"12","author":"FN New","year":"2022","unstructured":"New FN, Baer BR, Clark AG, Wells MT, Brito IL. Collective effects of human genomic variation on Microbiome function. Sci Rep. 2022;12(1):3839.","journal-title":"Sci Rep"},{"key":"934_CR340","doi-asserted-by":"crossref","unstructured":"Giau VV, Wu SY, Jamerlan A, An SSA, Kim SY, Hulme J. Gut microbiota and their neuroinflammatory implications in Alzheimer\u2019s Disease. Nutrients. 2018;10(11).","DOI":"10.3390\/nu10111765"},{"issue":"2","key":"934_CR341","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","volume":"19","author":"JF Cryan","year":"2020","unstructured":"Cryan JF, O\u2019Riordan KJ, Sandhu K, Peterson V, Dinan TG. The gut Microbiome in neurological disorders. Lancet Neurol. 2020;19(2):179\u201394.","journal-title":"Lancet Neurol"},{"issue":"11","key":"934_CR342","doi-asserted-by":"publisher","first-page":"e0187307","DOI":"10.1371\/journal.pone.0187307","volume":"12","author":"T Minato","year":"2017","unstructured":"Minato T, Maeda T, Fujisawa Y, Tsuji H, Nomoto K, Ohno K, et al. Progression of parkinson\u2019s Disease is associated with gut dysbiosis: Two-year follow-up study. PLoS ONE. 2017;12(11):e0187307.","journal-title":"PLoS ONE"},{"key":"934_CR343","doi-asserted-by":"crossref","unstructured":"Ochoa-Rep\u00e1raz J, Kirby TO, Kasper LH. The gut Microbiome and multiple sclerosis. Cold Spring Harb Perspect Med. 2018;8(6).","DOI":"10.1101\/cshperspect.a029017"},{"key":"934_CR344","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.conb.2019.11.009","volume":"61","author":"C Benakis","year":"2020","unstructured":"Benakis C, Martin-Gallausiaux C, Trezzi JP, Melton P, Liesz A, Wilmes P. The microbiome-gut-brain axis in acute and chronic brain Diseases. Curr Opin Neurobiol. 2020;61:1\u20139.","journal-title":"Curr Opin Neurobiol"},{"key":"934_CR345","doi-asserted-by":"publisher","first-page":"102177","DOI":"10.1016\/j.coi.2022.102177","volume":"76","author":"JW Bostick","year":"2022","unstructured":"Bostick JW, Schonhoff AM, Mazmanian SK. Gut microbiome-mediated regulation of neuroinflammation. Curr Opin Immunol. 2022;76:102177.","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"934_CR346","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4161\/gmic.28682","volume":"5","author":"M Lyte","year":"2014","unstructured":"Lyte M. Microbial endocrinology: Host-microbiota neuroendocrine interactions influencing brain and behavior. Gut Microbes. 2014;5(3):381\u20139.","journal-title":"Gut Microbes"},{"issue":"11","key":"934_CR347","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrmicro2876","volume":"10","author":"SM Collins","year":"2012","unstructured":"Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012;10(11):735\u201342.","journal-title":"Nat Rev Microbiol"},{"issue":"17\u201318","key":"934_CR348","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00508-020-01638-5","volume":"132","author":"F Leblhuber","year":"2020","unstructured":"Leblhuber F, Huemer J, Steiner K, Gostner JM, Fuchs D. Knock-on effect of periodontitis to the pathogenesis of Alzheimer\u2019s Disease? Wien Klin Wochenschr. 2020;132(17\u201318):493\u20138.","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"934_CR349","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/odi.14054","volume":"29","author":"V Parra-Torres","year":"2023","unstructured":"Parra-Torres V, Melgar-Rodr\u00edguez S, Mu\u00f1oz-Manr\u00edquez C, Sanhueza B, Cafferata EA, Paula-Lima AC, et al. Periodontal bacteria in the brain-Implication for Alzheimer\u2019s Disease: A systematic review. Oral Dis. 2023;29(1):21\u20138.","journal-title":"Oral Dis"},{"issue":"1","key":"934_CR350","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-210491","volume":"84","author":"T Werber","year":"2021","unstructured":"Werber T, Bata Z, Vaszine ES, Berente DB, Kamondi A, Horvath AA. The association of periodontitis and Alzheimer\u2019s Disease: how to hit two birds with one stone. J Alzheimers Dis. 2021;84(1):1\u201321.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"934_CR351","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1158\/1055-9965.EPI-05-0456","volume":"14","author":"CP Wild","year":"2005","unstructured":"Wild CP. Complementing the genome with an exposome: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1847\u201350.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"934_CR352","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jalz.2019.06.3914","volume":"15","author":"CE Finch","year":"2019","unstructured":"Finch CE, Kulminski AM. The Alzheimer\u2019s Disease exposome. Alzheimers Dement. 2019;15(9):1123\u201332.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"934_CR353","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/aje\/kwv325","volume":"184","author":"DG DeBord","year":"2016","unstructured":"DeBord DG, Carreon T, Lentz TJ, Middendorf PJ, Hoover MD, Schulte PA. Use of the exposome in the practice of epidemiology: A primer on -Omic technologies. Am J Epidemiol. 2016;184(4):302\u201314.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"934_CR354","doi-asserted-by":"publisher","first-page":"fcab308","DOI":"10.1093\/braincomms\/fcab308","volume":"4","author":"IK Karlsson","year":"2022","unstructured":"Karlsson IK, Escott-Price V, Gatz M, Hardy J, Pedersen NL, Shoai M, et al. Measuring heritable contributions to Alzheimer\u2019s Disease: polygenic risk score analysis with twins. Brain Commun. 2022;4(1):fcab308.","journal-title":"Brain Commun"},{"key":"934_CR355","doi-asserted-by":"publisher","first-page":"104511","DOI":"10.1016\/j.ebiom.2023.104511","volume":"90","author":"SJ Andrews","year":"2023","unstructured":"Andrews SJ, Renton AE, Fulton-Howard B, Podlesny-Drabiniok A, Marcora E, Goate AM. The complex genetic architecture of Alzheimer\u2019s Disease: novel insights and future directions. EBioMedicine. 2023;90:104511.","journal-title":"EBioMedicine"},{"issue":"1","key":"934_CR356","doi-asserted-by":"publisher","first-page":"e1022","DOI":"10.1038\/tp.2016.280","volume":"7","author":"M Cacciottolo","year":"2017","unstructured":"Cacciottolo M, Wang X, Driscoll I, Woodward N, Saffari A, Reyes J, et al. Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models. Transl Psychiatry. 2017;7(1):e1022.","journal-title":"Transl Psychiatry"},{"issue":"2","key":"934_CR357","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/geronb\/gbu064","volume":"70","author":"JA Ailshire","year":"2015","unstructured":"Ailshire JA, Clarke P. Fine particulate matter air pollution and cognitive function among U.S. Older adults. J Gerontol B Psychol Sci Soc Sci. 2015;70(2):322\u20138.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"3","key":"934_CR358","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000538630","volume":"53","author":"LNC Pelegrini","year":"2024","unstructured":"Pelegrini LNC, da Silva VA, Grigoli MM, Vatanabe IP, Manzine PR, Cominetti MR. Plasma ADAM10 levels and their association with Alzheimer\u2019s Disease diagnosis in older adults with fewer years of formal education. Dement Geriatr Cogn Disord. 2024;53(3):153\u201361.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"934_CR359","doi-asserted-by":"publisher","first-page":"e12402","DOI":"10.1002\/trc2.12402","volume":"9","author":"J Savold","year":"2023","unstructured":"Savold J, Cole M, Thorpe RJ. Jr. Barriers and solutions to Alzheimer\u2019s Disease clinical trial participation for black Americans. Alzheimers Dement (N Y). 2023;9(3):e12402.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"934_CR360","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/geronb\/gby071","volume":"74","author":"AB Scott","year":"2019","unstructured":"Scott AB, Reed RG, Garcia-Willingham NE, Lawrence KA, Segerstrom SC. Lifespan socioeconomic context: associations with cognitive functioning in later life. J Gerontol B Psychol Sci Soc Sci. 2019;74(1):113\u201325.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"934_CR361","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.socscimed.2016.11.019","volume":"172","author":"J Ailshire","year":"2017","unstructured":"Ailshire J, Karraker A, Clarke P. Neighborhood social stressors, fine particulate matter air pollution, and cognitive function among older U.S. Adults. Soc Sci Med. 2017;172:56\u201363.","journal-title":"Soc Sci Med"},{"key":"934_CR362","doi-asserted-by":"publisher","first-page":"172743","DOI":"10.1016\/j.pbb.2019.172743","volume":"184","author":"K Szczechowiak","year":"2019","unstructured":"Szczechowiak K, Diniz BS, Leszek J. Diet and Alzheimer\u2019s dementia - Nutritional approach to modulate inflammation. Pharmacol Biochem Behav. 2019;184:172743.","journal-title":"Pharmacol Biochem Behav"},{"key":"934_CR363","doi-asserted-by":"publisher","first-page":"525970","DOI":"10.3389\/fnins.2020.525970","volume":"14","author":"BA Mander","year":"2020","unstructured":"Mander BA. Local sleep and Alzheimer\u2019s Disease pathophysiology. Front Neurosci. 2020;14:525970.","journal-title":"Front Neurosci"},{"issue":"1","key":"934_CR364","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41386-019-0478-5","volume":"45","author":"C Wang","year":"2020","unstructured":"Wang C, Holtzman DM. Bidirectional relationship between sleep and Alzheimer\u2019s Disease: role of amyloid, tau, and other factors. Neuropsychopharmacology. 2020;45(1):104\u201320.","journal-title":"Neuropsychopharmacology"},{"key":"934_CR365","doi-asserted-by":"crossref","unstructured":"Musiek ES, Ju Y-ES. Targeting sleep and circadian function in the prevention of Alzheimer Disease. JAMA Neurol. 2022.","DOI":"10.1001\/jamaneurol.2022.1732"},{"key":"934_CR366","doi-asserted-by":"publisher","unstructured":"Lucey BA-OX, Liu H, Toedebusch CD, Freund D, Redrick T, Chahin SL, et al. Suvorexant acutely decreases Tau phosphorylation and A\u03b2 in the human CNS. LID\u2009 2023;1531\u20138249. https:\/\/doi.org\/10.1002\/ana.26641.","DOI":"10.1002\/ana.26641"},{"issue":"4","key":"934_CR367","doi-asserted-by":"publisher","first-page":"851","DOI":"10.5114\/aoms.2016.58928","volume":"13","author":"MS Ellulu","year":"2017","unstructured":"Ellulu MS, Patimah I, Khaza\u2019ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851\u201363.","journal-title":"Arch Med Sci"},{"key":"934_CR368","doi-asserted-by":"crossref","unstructured":"Cummings J, Ortiz A, Castellino J, Kinney J, Diabetes. Risk factor and translational therapeutic implications for Alzheimer\u2019s Disease. Eur J Neurosci. 2022.","DOI":"10.1111\/ejn.15619"},{"key":"934_CR369","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ebiom.2018.01.021","volume":"28","author":"J Ramos-Cejudo","year":"2018","unstructured":"Ramos-Cejudo J, Wisniewski T, Marmar C, Zetterberg H, Blennow K, de Leon MJ, et al. Traumatic brain injury and Alzheimer\u2019s Disease: the cerebrovascular link. EBioMedicine. 2018;28:21\u201330.","journal-title":"EBioMedicine"},{"issue":"9984","key":"934_CR370","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Lev\u00e4lahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255\u201363.","journal-title":"Lancet"},{"issue":"2","key":"934_CR371","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/alz.13365","volume":"20","author":"LD Baker","year":"2024","unstructured":"Baker LD, Snyder HM, Espeland MA, Whitmer RA, Kivipelto M, Woolard N, et al. Study design and methods: U.S. Study to protect brain health through lifestyle intervention to reduce risk (U.S. POINTER). Alzheimers Dement. 2024;20(2):769\u201382.","journal-title":"Alzheimers Dement"},{"key":"934_CR372","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences E, and Medicine. Preventing cognitive decline and dementia: a way forward.: the national academies press. 2017 [cited 2025 07\/11\/25]. Available from: https:\/\/doi.org\/10.17226\/24782.","DOI":"10.17226\/24782"},{"key":"934_CR373","unstructured":"National Academies of Sciences E, Medicine, Health, Medicine D, Board on Health Sciences P, Committee D, et al. In: Downey A, Stroud C, Landis S, Leshner AI, editors. Preventing cognitive decline and dementia: a way forward. Washington (DC): national academies press (US) Copyright 2017 by the national academy of sciences. All rights reserved.; 2017."},{"issue":"3","key":"934_CR374","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3233\/JAD-230861","volume":"97","author":"Y Han","year":"2024","unstructured":"Han Y, Huang C, Pan Y, Gu X. Single cell sequencing technology and its application in Alzheimer\u2019s Disease. J Alzheimers Dis. 2024;97(3):1033\u201350.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"934_CR375","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.3390\/cimb46050298","volume":"46","author":"Y Ma","year":"2024","unstructured":"Ma Y, Shi W, Dong Y, Sun Y, Jin Q. Spatial Multi-Omics in Alzheimer\u2019s Disease: A Multi-Dimensional approach to Understanding pathology and progression. Curr Issues Mol Biol. 2024;46(5):4968\u201390.","journal-title":"Curr Issues Mol Biol"},{"issue":"12","key":"934_CR376","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1002\/alz.13318","volume":"19","author":"Y Yakoub","year":"2023","unstructured":"Yakoub Y, Ashton NJ, Strikwerda-Brown C, Montoliu-Gaya L, Karikari TK, Kac PR, et al. Longitudinal blood biomarker trajectories in preclinical Alzheimer\u2019s Disease. Alzheimers Dement. 2023;19(12):5620\u201331.","journal-title":"Alzheimers Dement"},{"key":"934_CR377","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fmolb.2019.00158","volume":"6","author":"S Golriz Khatami","year":"2019","unstructured":"Golriz Khatami S, Robinson C, Birkenbihl C, Domingo-Fern\u00e1ndez D, Hoyt CT, Hofmann-Apitius M. Challenges of integrative Disease modeling in Alzheimer\u2019s Disease. Front Mol Biosci. 2019;6:158.","journal-title":"Front Mol Biosci"},{"issue":"5","key":"934_CR378","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jalz.2017.11.004","volume":"14","author":"K Li","year":"2018","unstructured":"Li K, O\u2019Brien R, Lutz M, Luo S. A prognostic model of Alzheimer\u2019s Disease relying on multiple longitudinal measures and time-to-event data. Alzheimers Dement. 2018;14(5):644\u201351.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"934_CR379","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1002\/alz.13390","volume":"19","author":"LM Winchester","year":"2023","unstructured":"Winchester LM, Harshfield EL, Shi L, Badhwar A, Khleifat AA, Clarke N, et al. Artificial intelligence for biomarker discovery in Alzheimer\u2019s Disease and dementia. Alzheimers Dement. 2023;19(12):5860\u201371.","journal-title":"Alzheimers Dement"},{"key":"934_CR380","doi-asserted-by":"publisher","first-page":"102857","DOI":"10.1016\/j.sbi.2024.102857","volume":"87","author":"F Angelucci","year":"2024","unstructured":"Angelucci F, Ai AR, Piendel L, Cerman J, Hort J. Integrating AI in fighting advancing Alzheimer: diagnosis, prevention, treatment, monitoring, mechanisms, and clinical trials. Curr Opin Struct Biol. 2024;87:102857.","journal-title":"Curr Opin Struct Biol"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00934-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00934-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00934-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:43:32Z","timestamp":1781635412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-026-00934-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":380,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00934-4","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.J.S. has participated in Scientific Advisory Boards (Bayer Oncology, Eisai, Novo Nordisk, and Siemens Medical Solutions USA, Inc.); served on an Observational Study Monitoring Board (MESA, NIH NHLBI); and served on External Advisory Committees for multiple NIA grants. He also serves as Editor-in-Chief of Brain Imaging and Behavior (Springer Nature).P.J.B., K.N., and N.E-T. declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}